1
|
Chang CA, Emberley E, D'Souza AL, Zhao W, Cosgrove C, Parrish KE, Mitra D, Payson E, Oleksijew A, Ellis P, Rodriguez L, Duggan R, Hrusch C, Lasko L, Assaily W, Zheng P, Liu W, Hernandez A, McCarthy K, Zhang Z, Rha G, Cao Z, Li Y, Perng O, Campbell J, Zhang G, Curran TS, Bruncko M, Marvin CC, Hobson AD, McPherson M, Uziel T, Pysz MA, Zhao X, Bankovich A, Hayflick J, McDevitt M, Freise KJ, Morgan-Lappe S, Purcell JW. ABBV-319: A CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies. Blood 2024:blood.2024023849. [PMID: 38701407 DOI: 10.1182/blood.2024023849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2024] [Revised: 04/22/2024] [Accepted: 04/22/2024] [Indexed: 05/05/2024] Open
Abstract
Glucocorticoids are key components of the current standard-of-care regimens (e.g., R-CHOP, EPOCH-R, Hyper-CVAD) for treatment of B-cell malignancy. However, systemic glucocorticoid treatment is associated with several adverse events. CD19 displays restricted expression in normal B-cells and is up-regulated in B-cell malignancies. ABBV-319 is a CD19-targeting antibody-drug conjugate (ADC) engineered to reduce glucocorticoid-associated toxicities while possessing three distinct mechanisms of action (MOA) to increase therapeutic efficacy: (1) antibody-mediated delivery of glucocorticoid receptor modulator (GRM) payload to activate apoptosis, (2) inhibition of CD19 signaling, and (3) enhanced Fc-mediated effector function via afucosylation of the antibody backbone. ABBV-319 elicited potent GRM-driven anti-tumor activity against multiple malignant B-cell lines in vitro as well as in cell line-derived xenografts (CDXs) and patient-derived xenografts (PDXs) in vivo. Remarkably, a single-dose of ABBV-319 induced sustained tumor regression and enhanced anti-tumor activity compared to repeat dosing of systemic prednisolone at the maximum tolerated dose (MTD) in mice. The unconjugated CD19 monoclonal antibody (mAb) also displayed anti-proliferative activity on a subset of B-cell lymphoma cell lines through the inhibition of PI3K signaling. Moreover, afucosylation of the CD19 mAb enhanced Fc-mediated antibody-dependent cellular cytotoxicity (ADCC), and this activity was maintained after conjugation with GRM payloads. Notably, ABBV-319 displayed superior efficacy compared to afucosylated CD19 mAb in human CD34+ PBMC-engrafted NSG-tg(Hu-IL15) transgenic mice, demonstrating enhanced anti-tumor activity when multiple MOAs are enabled. ABBV-319 also showed durable anti-tumor activity across multiple B-cell lymphoma PDX models, including non-germinal center B-cell (GCB) DLBCL and relapsed lymphoma post R-CHOP treatment. Collectively, these data support the ongoing evaluation of ABBV-319 in Phase I clinical trial (NCT05512390).
Collapse
Affiliation(s)
| | - Ethan Emberley
- AbbVie Inc., South San Francisco, California, United States
| | | | - Weilong Zhao
- AbbVie Inc., South San Francisco, California, United States
| | | | | | - Diya Mitra
- AbbVie Inc., North Chicago, Illinois, United States
| | - Elmer Payson
- AbbVie Inc., South San Francisco, California, United States
| | | | - Paul Ellis
- AbbVie Inc., North Chicago, Illinois, United States
| | | | - Ryan Duggan
- AbbVie Inc., North Chicago, Illinois, United States
| | - Cara Hrusch
- AbbVie Inc., North Chicago, Illinois, United States
| | - Loren Lasko
- AbbVie Inc., North Chicago, Illinois, United States
| | - Wissam Assaily
- AbbVie Inc., South San Francisco, California, United States
| | - Pingping Zheng
- AbbVie Inc., South San Francisco, California, United States
| | - Wei Liu
- AbbVie Inc., South San Francisco, California, United States
| | | | | | - Zhaomei Zhang
- AbbVie Inc., South San Francisco, California, United States
| | - Geunbae Rha
- AbbVie Inc., North Chicago, Illinois, United States
| | | | - Yingchun Li
- AbbVie Inc., North Chicago, Illinois, United States
| | - Olivia Perng
- AbbVie Inc., South San Francisco, California, United States
| | - Jos Campbell
- AbbVie Inc., South San Francisco, California, United States
| | - Gloria Zhang
- AbbVie Inc., South San Francisco, California, United States
| | | | | | | | | | | | - Tamar Uziel
- AbbVie Inc., North Chicago, Illinois, United States
| | | | - Xi Zhao
- AbbVie Inc., South San Francisco, California, United States
| | | | - Joel Hayflick
- AbbVie Inc., South San Francisco, California, United States
| | | | | | | | | |
Collapse
|
2
|
Piccolo LR, Roby E, Canfield CF, Seery AM, Weisleder A, Cates CB, Tutasig L, Matalon M, Custode A, Rodriguez L, Mendelsohn AL. Supporting responsive parenting in real-world implementation: minimal effective dose of the Video Interaction Project. Pediatr Res 2024; 95:1295-1300. [PMID: 38040989 DOI: 10.1038/s41390-023-02916-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 10/12/2023] [Accepted: 11/03/2023] [Indexed: 12/03/2023]
Abstract
BACKGROUND The Video Interaction Project (VIP) is a healthcare-based intervention that provides real-time video-feedback of parent-child play and reading interactions to families with children aged 0 to 36 months. Although evidence from randomized controlled trials demonstrates improved early relational health, including responsive parenting, after three to five VIP visits, the minimal effective dose in real-world implementations is unknown. This study aimed to determine the minimal effective dose of VIP during a real-world implementation for changing responsive parenting behaviors. METHODS We performed a longitudinal prospective study of 183 dyads at a public hospital pediatric clinic. Responsive parenting behaviors were assessed with an observational checklist utilized as part of standard VIP practice at baseline and two follow-up VIP visits. RESULTS Multilevel models adjusted for baseline sociodemographics (child's sex and age, and maternal education) and time between visits showed that responsive parenting behaviors during parent-child reading and play significantly increased after a single VIP visit (Cohen's d = 0.52, p < 0.05) with additional impact following completion of a second visit (cumulative for 2 visits: d = 0.76, p < 0.05). CONCLUSIONS A single VIP visit is associated with increased responsive parenting behaviors. Findings support offering VIP widely, regardless of capacity to ensure attendance at multiple visits. IMPACT This is the first study showing the minimal effective dose of the Video Interaction Project (VIP) for increasing responsive parenting behaviors. Responsive parenting behaviors increased by over 22% following a single VIP visit, with a cumulative increase of 37% following the second visit compared to baseline. Findings have important implications for implementation and scalability of pediatric-based preventive programs that support early relational health through activities such as reading and play.
Collapse
Affiliation(s)
- Luciane R Piccolo
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA
| | - Erin Roby
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA
| | - Caitlin F Canfield
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA
| | - Anne M Seery
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA
| | - Adriana Weisleder
- Department of Communication Sciences and Disorders, Northwestern University, Evanston, IL, USA
| | - Carolyn Brockmeyer Cates
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA
- Department of Psychology, School of Natural and Social Sciences, Purchase College, State University of New York, Purchase, NY, USA
| | - Leonela Tutasig
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA
| | - Maya Matalon
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA
| | - Aida Custode
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA
| | - Luis Rodriguez
- Department of Pediatrics, Woodhull Medical Center Brooklyn, Brooklyn, NY, USA
| | - Alan L Mendelsohn
- Department of Pediatrics, Division of Developmental and Behavioral Pediatrics, NYU Grossman School of Medicine, New York, NY, USA.
| |
Collapse
|
3
|
Ren J, Rodriguez L, Johnson T, Henning A, Dhaher YY. 17β-Estradiol Effects in Skeletal Muscle: A 31P MR Spectroscopic Imaging (MRSI) Study of Young Females during Early Follicular (EF) and Peri-Ovulation (PO) Phases. Diagnostics (Basel) 2024; 14:235. [PMID: 38337751 PMCID: PMC10854839 DOI: 10.3390/diagnostics14030235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2023] [Revised: 01/18/2024] [Accepted: 01/21/2024] [Indexed: 02/12/2024] Open
Abstract
The natural variation in estrogen secretion throughout the female menstrual cycle impacts various organs, including estrogen receptor (ER)-expressed skeletal muscle. Many women commonly experience increased fatigue or reduced energy levels in the days leading up to and during menstruation, when blood estrogen levels decline. Yet, it remains unclear whether endogenous 17β-estradiol, a major estrogen component, directly affects the energy metabolism in skeletal muscle due to the intricate and fluctuating nature of female hormones. In this study, we employed 2D 31P FID-MRSI at 7T to investigate phosphoryl metabolites in the soleus muscle of a cohort of young females (average age: 28 ± 6 years, n = 7) during the early follicular (EF) and peri-ovulation (PO) phases, when their blood 17β-estradiol levels differ significantly (EF: 28 ± 18 pg/mL vs. PO: 71 ± 30 pg/mL, p < 0.05), while the levels of other potentially interfering hormones remain relatively invariant. Our findings reveal a reduction in ATP-referenced phosphocreatine (PCr) levels in the EF phase compared to the PO phase for all participants (5.4 ± 4.3%). Furthermore, we observe a linear correlation between muscle PCr levels and blood 17β-estradiol concentrations (r = 0.64, p = 0.014). Conversely, inorganic phosphate Pi and phospholipid metabolite GPC levels remain independent of 17β-estradiol but display a high correlation between the EF and PO phases (p = 0.015 for Pi and p = 0.0008 for GPC). The robust association we have identified between ATP-referenced PCr and 17β-estradiol suggests that 17β-estradiol plays a modulatory role in the energy metabolism of skeletal muscle.
Collapse
Affiliation(s)
- Jimin Ren
- Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA;
- Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
| | - Luis Rodriguez
- Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA;
- Department of Physical Medicine and Rehabilitation, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
| | - Talon Johnson
- Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA;
| | - Anke Henning
- Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA;
- Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
| | - Yasin Y. Dhaher
- Department of Bioengineering, University of Texas at Dallas, Richardson, TX 75080, USA;
- Department of Physical Medicine and Rehabilitation, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
- Peter O’Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
| |
Collapse
|
4
|
Kuebler B, Alvarez-Palomo B, Aran B, Castaño J, Rodriguez L, Raya A, Querol Giner S, Veiga A. Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population. Stem Cell Res Ther 2023; 14:366. [PMID: 38093328 PMCID: PMC10720139 DOI: 10.1186/s13287-023-03576-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Accepted: 11/16/2023] [Indexed: 12/17/2023] Open
Abstract
BACKGROUND Induced pluripotent stem cell (iPSC)-derived cell therapies are an interesting new area in the field of regenerative medicine. One of the approaches to decrease the costs of iPSC-derived therapies is the use of allogenic homozygous human leukocyte antigen (HLA)-matched donors to generate iPSC lines and to build a clinical-grade iPSC bank covering a high percentage of the Spanish population. METHODS The Spanish Stem Cell Transplantation Registry was screened for cord blood units (CBUs) homozygous for the most common HLA-A, HLA-B and HLA-DRB1 haplotypes. Seven donors were selected with haplotypes covering 21.37% of the haplotypes of the Spanish population. CD34-positive hematopoietic progenitors were isolated from the mononuclear cell fraction of frozen cord blood units from each donor by density gradient centrifugation and further by immune magnetic labeling and separation using purification columns. Purified CD34 + cells were reprogrammed to iPSCs by transduction with the CTS CytoTune-iPS 2.1 Sendai Reprogramming Kit. RESULTS The iPSCs generated from the 7 donors were expanded, characterized, banked and registered. Master cell banks (MCBs) and working cell banks (WCBs) from the iPSCs of each donor were produced under GMP conditions in qualified clean rooms. CONCLUSIONS Here, we present the first clinical-grade, iPSC haplobank in Spain made from CD34 + cells from seven cord blood units homozygous for the most common HLA-A, HLA-B and HLA-DRB1 haplotypes within the Spanish population. We describe their generation by transduction with Sendai viral vectors and their GMP-compliant expansion and banking. These haplolines will constitute starting materials for advanced therapy medicinal product development (ATMP).
Collapse
Affiliation(s)
- B Kuebler
- Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain
- Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain
| | - B Alvarez-Palomo
- Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain
| | - B Aran
- Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain
- Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain
| | - J Castaño
- Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain
- Advanced Therapy Platform, Hospital Sant Joan de Déu de Barcelona, Pg. de Sant Joan de Déu, 2, Espluges de Llobregat, 08950, Barcelona, Spain
| | - L Rodriguez
- Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain
| | - A Raya
- Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
- Stem Cell Potency Group, Regenerative Medicine Program, Institut d´Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
- Centre for Networked Biomedical Research On Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
- Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain.
| | - S Querol Giner
- Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain.
- Transfusional Medicine Group, Vall d'Hebron Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain.
| | - A Veiga
- Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
- Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
| |
Collapse
|
5
|
Chitta LP, Zhukov AN, Berghmans D, Peter H, Parenti S, Mandal S, Aznar Cuadrado R, Schühle U, Teriaca L, Auchère F, Barczynski K, Buchlin É, Harra L, Kraaikamp E, Long DM, Rodriguez L, Schwanitz C, Smith PJ, Verbeeck C, Seaton DB. Picoflare jets power the solar wind emerging from a coronal hole on the Sun. Science 2023; 381:867-872. [PMID: 37616348 DOI: 10.1126/science.ade5801] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2022] [Accepted: 07/14/2023] [Indexed: 08/26/2023]
Abstract
Coronal holes are areas on the Sun with open magnetic field lines. They are a source region of the solar wind, but how the wind emerges from coronal holes is not known. We observed a coronal hole using the Extreme Ultraviolet Imager on the Solar Orbiter spacecraft. We identified jets on scales of a few hundred kilometers, which last 20 to 100 seconds and reach speeds of ~100 kilometers per second. The jets are powered by magnetic reconnection and have kinetic energy in the picoflare range. They are intermittent but widespread within the observed coronal hole. We suggest that such picoflare jets could produce enough high-temperature plasma to sustain the solar wind and that the wind emerges from coronal holes as a highly intermittent outflow at small scales.
Collapse
Affiliation(s)
- L P Chitta
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - A N Zhukov
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
- Skobeltsyn Institute of Nuclear Physics, Moscow State University, Moscow 119991, Russia
| | - D Berghmans
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
| | - H Peter
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - S Parenti
- Institut d'Astrophysique Spatiale, Centre National de la Recherche Scientifique, Université Paris-Saclay, 91405 Orsay, France
| | - S Mandal
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - R Aznar Cuadrado
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - U Schühle
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - L Teriaca
- Max-Planck-Institut für Sonnensystemforschung, 37077 Göttingen, Germany
| | - F Auchère
- Institut d'Astrophysique Spatiale, Centre National de la Recherche Scientifique, Université Paris-Saclay, 91405 Orsay, France
| | - K Barczynski
- Physikalisch-Meteorologisches Observatorium Davos, World Radiation Center, 7260 Davos Dorf, Switzerland
- Eidgenössische Technische Hochschule Zürich, 8093 Zürich, Switzerland
| | - É Buchlin
- Institut d'Astrophysique Spatiale, Centre National de la Recherche Scientifique, Université Paris-Saclay, 91405 Orsay, France
| | - L Harra
- Physikalisch-Meteorologisches Observatorium Davos, World Radiation Center, 7260 Davos Dorf, Switzerland
- Eidgenössische Technische Hochschule Zürich, 8093 Zürich, Switzerland
| | - E Kraaikamp
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
| | - D M Long
- Mullard Space Science Laboratory, University College London, Dorking, Surrey RH5 6NT, UK
- Astrophysics Research Centre, School of Mathematics and Physics, Queen's University Belfast, Belfast BT7 1NN, Northern Ireland, UK
| | - L Rodriguez
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
| | - C Schwanitz
- Physikalisch-Meteorologisches Observatorium Davos, World Radiation Center, 7260 Davos Dorf, Switzerland
- Eidgenössische Technische Hochschule Zürich, 8093 Zürich, Switzerland
| | - P J Smith
- Mullard Space Science Laboratory, University College London, Dorking, Surrey RH5 6NT, UK
| | - C Verbeeck
- Solar-Terrestrial Centre of Excellence, Solar Influences Data Analysis Centre, Royal Observatory of Belgium, 1180 Brussels, Belgium
| | - D B Seaton
- Southwest Research Institute, Boulder, CO 80302, USA
| |
Collapse
|
6
|
Cheng X, Priest ER, Li HT, Chen J, Aulanier G, Chitta LP, Wang YL, Peter H, Zhu XS, Xing C, Ding MD, Solanki SK, Berghmans D, Teriaca L, Aznar Cuadrado R, Zhukov AN, Guo Y, Long D, Harra L, Smith PJ, Rodriguez L, Verbeeck C, Barczynski K, Parenti S. Author Correction: Ultra-high-resolution observations of persistent null-point reconnection in the solar corona. Nat Commun 2023; 14:2372. [PMID: 37185588 PMCID: PMC10130028 DOI: 10.1038/s41467-023-38149-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/17/2023] Open
Affiliation(s)
- X Cheng
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China.
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany.
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China.
| | - E R Priest
- School of Mathematics and Statistics, University of St. Andrews, Fife, KY16 9SS, Scotland, UK
| | - H T Li
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - J Chen
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - G Aulanier
- Sorbonne Université, Observatoire de Paris - PSL, École Polytechnique, IP Paris, CNRS, Laboratory for Plasma Physics (LPP), 4 place Jussieu, 75005, Paris, France
- Rosseland Centre for Solar Physics, Institute for Theoretical Astrophysics, Universitetet i Oslo, P.O. Box 1029, Blindern, 0315, Oslo, Norway
| | - L P Chitta
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - Y L Wang
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - H Peter
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - X S Zhu
- State Key Laboratory of Space Weather, National Space Science Center, Chinese Academy of Sciences, Beijing, China
| | - C Xing
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Sorbonne Université, Observatoire de Paris - PSL, École Polytechnique, IP Paris, CNRS, Laboratory for Plasma Physics (LPP), 4 place Jussieu, 75005, Paris, France
| | - M D Ding
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - S K Solanki
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - D Berghmans
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - L Teriaca
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - R Aznar Cuadrado
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - A N Zhukov
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
- Skobeltsyn Institute of Nuclear Physics, Moscow State University, 119992, Moscow, Russia
| | - Y Guo
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - D Long
- Mullard Space Science Laboratory, University College London, Holmbury St. Mary, Dorking, Surrey, RH5 6NT, UK
| | - L Harra
- PMOD/WRC, Dorfstrasse 33, CH-7260, Davos Dorf, Switzerland
- ETH-Zürich, Wolfang-Pauli-Strasse 27, HIT J 22.4, 8093, Zürich, Switzerland
| | - P J Smith
- Mullard Space Science Laboratory, University College London, Holmbury St. Mary, Dorking, Surrey, RH5 6NT, UK
| | - L Rodriguez
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - C Verbeeck
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - K Barczynski
- ETH-Zürich, Wolfang-Pauli-Strasse 27, HIT J 22.4, 8093, Zürich, Switzerland
| | - S Parenti
- Institut d'Astrophysique Spatiale, Université Paris-Saclay, 91405, Orsay Cedex, France
| |
Collapse
|
7
|
Cheng X, Priest ER, Li HT, Chen J, Aulanier G, Chitta LP, Wang YL, Peter H, Zhu XS, Xing C, Ding MD, Solanki SK, Berghmans D, Teriaca L, Aznar Cuadrado R, Zhukov AN, Guo Y, Long D, Harra L, Smith PJ, Rodriguez L, Verbeeck C, Barczynski K, Parenti S. Ultra-high-resolution observations of persistent null-point reconnection in the solar corona. Nat Commun 2023; 14:2107. [PMID: 37055427 PMCID: PMC10102217 DOI: 10.1038/s41467-023-37888-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Accepted: 03/30/2023] [Indexed: 04/15/2023] Open
Abstract
Magnetic reconnection is a key mechanism involved in solar eruptions and is also a prime possibility to heat the low corona to millions of degrees. Here, we present ultra-high-resolution extreme ultraviolet observations of persistent null-point reconnection in the corona at a scale of about 390 km over one hour observations of the Extreme-Ultraviolet Imager on board Solar Orbiter spacecraft. The observations show formation of a null-point configuration above a minor positive polarity embedded within a region of dominant negative polarity near a sunspot. The gentle phase of the persistent null-point reconnection is evidenced by sustained point-like high-temperature plasma (about 10 MK) near the null-point and constant outflow blobs not only along the outer spine but also along the fan surface. The blobs appear at a higher frequency than previously observed with an average velocity of about 80 km s-1 and life-times of about 40 s. The null-point reconnection also occurs explosively but only for 4 minutes, its coupling with a mini-filament eruption generates a spiral jet. These results suggest that magnetic reconnection, at previously unresolved scales, proceeds continually in a gentle and/or explosive way to persistently transfer mass and energy to the overlying corona.
Collapse
Affiliation(s)
- X Cheng
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China.
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany.
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China.
| | - E R Priest
- School of Mathematics and Statistics, University of St. Andrews, Fife, KY16 9SS, Scotland, UK
| | - H T Li
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - J Chen
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - G Aulanier
- Sorbonne Université, Observatoire de Paris - PSL, École Polytechnique, IP Paris, CNRS, Laboratory for Plasma Physics (LPP), 4 place Jussieu, 75005, Paris, France
- Rosseland Centre for Solar Physics, Institute for Theoretical Astrophysics, Universitetet i Oslo, P.O. Box 1029, Blindern, 0315, Oslo, Norway
| | - L P Chitta
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - Y L Wang
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - H Peter
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - X S Zhu
- State Key Laboratory of Space Weather, National Space Science Center, Chinese Academy of Sciences, Beijing, China
| | - C Xing
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Sorbonne Université, Observatoire de Paris - PSL, École Polytechnique, IP Paris, CNRS, Laboratory for Plasma Physics (LPP), 4 place Jussieu, 75005, Paris, France
| | - M D Ding
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - S K Solanki
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - D Berghmans
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - L Teriaca
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - R Aznar Cuadrado
- Max Planck Institute for Solar System Research, 37077, Göttingen, Germany
| | - A N Zhukov
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
- Skobeltsyn Institute of Nuclear Physics, Moscow State University, 119992, Moscow, Russia
| | - Y Guo
- School of Astronomy and Space Science, Nanjing University, 210093, Nanjing, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, 210093, Nanjing, China
| | - D Long
- Mullard Space Science Laboratory, University College London, Holmbury St. Mary, Dorking, Surrey, RH5 6NT, UK
| | - L Harra
- PMOD/WRC, Dorfstrasse 33, CH-7260, Davos Dorf, Switzerland
- ETH-Zürich, Wolfang-Pauli-Strasse 27, HIT J 22.4, 8093, Zürich, Switzerland
| | - P J Smith
- Mullard Space Science Laboratory, University College London, Holmbury St. Mary, Dorking, Surrey, RH5 6NT, UK
| | - L Rodriguez
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - C Verbeeck
- Solar-Terrestrial Centre of Excellence - SIDC, Royal Observatory of Belgium, Ringlaan -3- Av. Circulaire, 1180, Brussels, Belgium
| | - K Barczynski
- ETH-Zürich, Wolfang-Pauli-Strasse 27, HIT J 22.4, 8093, Zürich, Switzerland
| | - S Parenti
- Institut d'Astrophysique Spatiale, Université Paris-Saclay, 91405, Orsay Cedex, France
| |
Collapse
|
8
|
Caruana E, Salomon J, Rodriguez L, Boutoille D. Descriptive management of suspected acute cystitis in adult patients by French general practitioners during remote consultation. Infect Dis Now 2023; 53:104707. [PMID: 37044246 DOI: 10.1016/j.idnow.2023.104707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Revised: 03/15/2023] [Accepted: 04/01/2023] [Indexed: 04/14/2023]
Abstract
OBJECTIVES The main objective of this study was to analyze French general practitioners' (GP) online prescriptions for suspected acute cystitis using a single nationwide teleconsultation platform. PATIENTS AND METHODS First, a descriptive study of management for suspected cystitis was conducted from the 1st of January to the 31st of December 2020. After which, following pedagogical intervention, a pre/post descriptive analysis of the antibiotics prescribed was carried out. RESULTS Some 496,041 teleconsultations (TCs) were carried out in 2020 on the Qare platform. Among them, 15089 TCs for cystitis with ICD-10 encoding (N30) were analyzed. Fosfomycin trometamol was the most prescribed antibiotic (n=10297, 69%), while fluoroquinolones (n=1568, 10.6%) were the second. Urine test strip was prescribed in 3157 (20%) and urine culture in 7033 (47%) of the TCs. July-August 2020 and July-August 2021 were compared and while a significant drop in fluoroquinolone prescriptions and a major increase in Fosfomycin trometamol were observed, there was no change in the prescriptions of urine culture. An average antibiotic conformity rate of 61.5% was observed before the intervention, and 68.8% afterwards. CONCLUSIONS Cystitis is a recurrent reason for remote consultation. The study demonstrated sizable over-prescription of urine culture, ultrasound, and fluoroquinolones. Intervention should be improved and strengthened to guarantee continuous training and awareness of GP's on appropriate cystitis prescriptions in telemedicine.
Collapse
Affiliation(s)
- E Caruana
- Cabinet de médecine générale, 56 Rue Charles Rivière, 44400 Rezé 75008 Paris
| | - J Salomon
- Pédiatre MD, PhD, Directrice Médicale Adjointe Qare, Référente Médicale Formation et Qualité, 36, avenue Pierre 1er de Serbie 75008 Paris
| | - L Rodriguez
- Infirmier Support et Formation Qare. 36 Avenue Pierre 1er de Serbie
| | - D Boutoille
- Infectiologue CHU de Nantes, CHU de Nantes, 1 place Alexis Ricordeau 44093, Nantes
| |
Collapse
|
9
|
Rodriguez L, Tomer Y, Carson P, Dimopoulos T, Zhao M, Chavez K, Iyer S, Huang L, Ebert C, Sereda L, Murthy A, Trujillo G, Beers MF, Katzen J. Chronic Expression of a Clinical SFTPC Mutation Causes Murine Lung Fibrosis with Idiopathic Pulmonary Fibrosis Features. Am J Respir Cell Mol Biol 2023; 68:358-365. [PMID: 36473455 PMCID: PMC10112421 DOI: 10.1165/rcmb.2022-0203ma] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Accepted: 12/06/2022] [Indexed: 12/12/2022] Open
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic interstitial lung disease. A barrier to developing more effective therapies for IPF is the dearth of preclinical models that recapitulate the early pathobiology of this disease. Intratracheal bleomycin, the conventional preclinical murine model of IPF, fails to reproduce the intrinsic dysfunction to the alveolar epithelial type 2 cell (AEC2) that is believed to be a proximal event in the pathogenesis of IPF. Murine fibrosis models based on SFTPC (Surfactant Protein C gene) mutations identified in patients with interstitial lung disease cause activation of the AEC2 unfolded protein response and endoplasmic reticulum stress-an AEC2 dysfunction phenotype observed in IPF. Although these models achieve spontaneous fibrosis, they do so with precedent lung injury and thus are challenged to phenocopy the general clinical course of patients with IPF-gradual progressive fibrosis and loss of lung function. Here, we report a refinement of a murine Sftpc mutation model to recapitulate the clinical course, physiological impairment, parenchymal cellular composition, and biomarkers associated with IPF. This platform provides the field with an innovative model to understand IPF pathogenesis and index preclinical therapeutic candidates.
Collapse
Affiliation(s)
- Luis Rodriguez
- Pulmonary, Allergy, and Critical Care Medicine Division and
| | - Yaniv Tomer
- Pulmonary, Allergy, and Critical Care Medicine Division and
| | - Paige Carson
- Pulmonary, Allergy, and Critical Care Medicine Division and
| | | | - Ming Zhao
- Pulmonary, Allergy, and Critical Care Medicine Division and
| | - Katrina Chavez
- Pulmonary, Allergy, and Critical Care Medicine Division and
| | - Swati Iyer
- Pulmonary, Allergy, and Critical Care Medicine Division and
| | - Li Huang
- Fibrosis Biology Drug Discovery, Bristol-Myers Squibb, Lawrenceville, New Jersey; and
| | - Christina Ebert
- Fibrosis Biology Drug Discovery, Bristol-Myers Squibb, Lawrenceville, New Jersey; and
| | - Larisa Sereda
- Fibrosis Biology Drug Discovery, Bristol-Myers Squibb, Lawrenceville, New Jersey; and
| | - Aditi Murthy
- Pulmonary, Allergy, and Critical Care Medicine Division and
| | - Glenda Trujillo
- Fibrosis Biology Drug Discovery, Bristol-Myers Squibb, Lawrenceville, New Jersey; and
| | - Michael F. Beers
- Pulmonary, Allergy, and Critical Care Medicine Division and
- PENN–CHOP Lung Biology Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
- The Michael Crescenz VA Medical Center, Philadelphia, Pennsylvania
| | - Jeremy Katzen
- Pulmonary, Allergy, and Critical Care Medicine Division and
- PENN–CHOP Lung Biology Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
| |
Collapse
|
10
|
Simonson A, Flores J, Anderson E, Moreno C, Plasko G, Papadopoulos KP, Patnaik A, Rasco D, Rodriguez G, Lang A, Beeram M, Rodriguez L, Drengler R, Abbate S, Salih H, Smith L, Elmi M, DeBerry B, Rosenthal A, Hernandez T, Lakhani N, Sharma M, Wick M. Abstract P3-08-05: Correlation of Trop2 expression with in vivo sensitivity to sacituzumab govitecan in a panel of breast XPDX models. Cancer Res 2023. [DOI: 10.1158/1538-7445.sabcs22-p3-08-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
Abstract
Abstract
Background: Sacituzumab govitecan (SG) is an antibody-drug conjugate targeting Trop2 with an SN-38 payload recently approved for pretreated patients with locally advanced or metastatic triple-negative breast cancer (TNBC). The XenoSTART Patient-Derived Xenograft (XPDX) breast cancer platform includes over 180 models spanning all subtypes characterized with immunohistochemistry (IHC) including ER, PR, and HER2 protein levels, genomic and transcriptomic sequencing, and in vivo drug sensitivity. To better understand potential benefit of SG in breast cancers other than TNBC and further annotate our platform, Trop2 protein levels were determined in all breast models by IHC. We evaluated tumor growth inhibition by SG in 125 of our XPDX breast models and compared protein expression with agent activity. Methods: 180 breast XPDX models were evaluated for Trop2 expression (AF650, R&D Systems) and 125 were evaluated in vivo against SG; responses were grouped by ER and Trop2 status (+/-). Models were grown subcutaneously in female athymic nude mice and ER+ models supplemented with estradiol. Models were also characterized for PR, HER2, and AR protein expression by IHC and profiled using WES and RNAseq. For in vivo studies, SG was administered by intravenous injection biweekly for two cycles at 1 mg, flat; endpoints included tumor volume and time from treatment initiation with %T/C values and tumor regression reported at study completion; a T/C of ≤ 20% versus control was considered sensitive. Tumor regression (%T/C< 0%) versus Day 0 tumor volume was also reported. Results: 180 breast models were examined by IHC with 75/180 (42%) classified as ER+ and 105/180 (58%) ER-. In ER+ models 38/75 (51%) were Trop2+ and 37/75 (49%) Trop2-, and in ER- models 41/105 (39%) were Trop2+ and 64/105 (61%) Trop2-. In vivo, 20% of ER+/Trop2+ models reported sensitivity to SG, most notably models from patients with acquired resistance to CDK4/6 inhibitors, including STM001 and ST4316B. Interestingly, >70% of ER+/HER2+/Trop2+ models were insensitive to SG, including ST225 and ST340. Of 41 ER-/Trop2+ models, approximately 40% reported some response to SG with 50% of these sensitive to therapy, including ST5954 established from a patient who began treatment with SG following sample collection and is currently in remission. >75% of Trop2- models were insensitive to SG regardless of ER status. Conclusion: We screened 180 models in our XPDX breast cancer platform for Trop2 expression and compared expression with in vivo SG efficacy in 125 models. Analysis is underway to correlate receptor and molecular profiles with SG sensitivity in breast models and we are expanding expression and in vivo testing to additional indications.
Citation Format: Alyssa Simonson, Johnnie Flores, Ebony Anderson, Crystal Moreno, George Plasko, Kyriakos P. Papadopoulos, Amita Patnaik, Drew Rasco, Gladys Rodriguez, Amy Lang, Muralidhar Beeram, Luis Rodriguez, Ronald Drengler, Steven Abbate, Hanni Salih, Lon Smith, Maryam Elmi, Brittany DeBerry, Arthur Rosenthal, Tatiana Hernandez, Nehal Lakhani, Manish Sharma, Michael Wick. Correlation of Trop2 expression with in vivo sensitivity to sacituzumab govitecan in a panel of breast XPDX models [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr P3-08-05.
Collapse
|
11
|
Bertram MR, Rodgers C, Reed K, Velazquez-Salinas L, Pelzel-McCluskey A, Mayo C, Rodriguez L. Vesicular stomatitis Indiana virus near-full-length genome sequences reveal low genetic diversity during the 2019 outbreak in Colorado, USA. Front Vet Sci 2023; 10:1110483. [PMID: 36865437 PMCID: PMC9971496 DOI: 10.3389/fvets.2023.1110483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 01/30/2023] [Indexed: 02/16/2023] Open
Affiliation(s)
- Miranda R. Bertram
- Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Greenport, NY, United States
| | - Case Rodgers
- Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, United States
| | - Kirsten Reed
- Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, United States
| | - Lauro Velazquez-Salinas
- Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Greenport, NY, United States
| | - Angela Pelzel-McCluskey
- Veterinary Services, Animal and Plant Health Inspection Service, United States Department of Agriculture, Fort Collins, CO, United States
| | - Christie Mayo
- Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, United States
| | - Luis Rodriguez
- Foreign Animal Disease Research Unit, Plum Island Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Greenport, NY, United States,*Correspondence: Luis Rodriguez ✉
| |
Collapse
|
12
|
Bottini O, Rodriguez Santos F, Boroda A, Arias F, Calcina D, Agüero Wagner C, Grillo L, Morales Bazurto M, Santiago F, Nigro J, Morales M, Ferreyra M, Perea Ansinelli A, Diaz M, Segura J, Mazzurco M, Diez G, Halusch E, Ovelar J, Parrotta L, Fernandez J, Avramovic M, Ríos J, Esposito A, Alfonso H, Desjardins E, Arias L, Joviliano E, Toledo DE Aguiar E, Barreto Dos Santos J, Orrego A, Bombín J, Pizarro I, Cabezas J, Manosalvas R, Villota V, Rodriguez L, Martínez Granados A, Mérida J, García Bernard D, Serralde J, Vega Rasgado F, Teixeira E, Filizzola R, Corbeta R, Benito R, Chunga Prieto J, Rivera T, Volpi M, Sarutte S, Ortiz P, Prego A, Navas H, Alberti T, Guglielmone D, Mejía R, Simkin C, Intriago E, Bercovich J. The First Latin American Consensus on Superficial and Perforating Venous Mapping. INT ANGIOL 2023; 42:45-58. [PMID: 36892521 DOI: 10.23736/s0392-9590.23.04991-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/10/2023]
Abstract
With the aim of obtaining a map which is useful as a diagnostic tool and therapeutical orientation, complementing the written report of duplex ultrasound venous study, Latin-American Scientific Societies of Phlebology, Vascular Surgery and Vascular Imaging were invited to participate, through their regional representatives, to the First Consensus of Superficial and Perforating Venous Mapping. A consensus process using a modified Delphi method was carried out. An International Working Group was formed, which developed a Prototype of the Venous Mapping that worked as a starting point for consensus, and was presented in a first virtual meeting of 54 experts (societies' representatives) when the methodology was explained. For the consensus process, two rounds of self-administrated questionnaires with feedback were used. In the first questionnaire a 100% consensus was obtained in the 15 statements (an agreement range of 85.2% to 100%) In the analysis of qualitative data, three categories according to the actions to implement were identified - actions which involved no action, minor changes and major changes. This analysis was used to build the second questionnaire, which reached a consensus in its six statements (agreement range of 87.1% to 98.1%). A final consensus on every field proposed was established with the approval of all the experts consulted and it was presented at a third online meeting. The document of the superficial and perforating venous mapping reached by consensus is presented hereafter.
Collapse
Affiliation(s)
- Oscar Bottini
- Hospital Alemán, Universidad del Salvador, Buenos Aires, Argentina - .,Centro Medico Bottini, Buenos Aires, Argentina - .,Forum Venoso Latinoamericano, Buenos Aires, Argentina - .,Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina -
| | | | - Alejandro Boroda
- Hospital Alemán, Universidad del Salvador, Buenos Aires, Argentina.,Centro Medico Bottini, Buenos Aires, Argentina
| | | | - Daniela Calcina
- Hospital Alemán, Universidad del Salvador, Buenos Aires, Argentina.,Centro Medico Bottini, Buenos Aires, Argentina
| | - Chantal Agüero Wagner
- Clínica Vanguardia, Asunción, Paraguay.,Sociedad Paraguaya de Flebología y Linfología (SPFL), Asunción, Paraguay
| | - Lorena Grillo
- Hospital San Rafael de Ajuela, Universidad de Ciencias Medicas, Ajuela, Costa Rica.,Asociación de Cirujanos Vasculares Periféricos de Costa Rica, Ajuela, Costa Rica
| | | | - Fabricio Santiago
- Hospital Geral de Goiânia, Universidade Federal de Goiás, Goiânia, Brazil.,Sociedad Brasileña de Angiología y Cirugía Vascular, Goiânia, Brazil
| | - Juan Nigro
- Asociación Argentina de Angiología y Cirugía Cardiovascular (AAAyCCV), Buenos Aires, Argentina
| | - Marcelo Morales
- Asociación Cordobesa de Flebología y Linfología, Córdoba, Argentina
| | - Martín Ferreyra
- Asociación Cuyana de Flebología, Linfología y Arteriopatías, Cuyo, Argentina
| | | | - Monserrat Diaz
- Asociación de Flebología y Linfología de la Patagonia, Neuquen, Argentina
| | - Jorge Segura
- Asociación de Flebología y Linfología de la Provincia de Buenos Aires (AFLIPBA), Buenos Aires, Argentina
| | - Martín Mazzurco
- Asociación de Flebología y Linfología de Rosario, Rosario, Argentina
| | - Guillermo Diez
- Asociación de Flebología y Linfología de Rosario, Rosario, Argentina
| | - Eduardo Halusch
- Asociación de Flebología y Linfología de Salta, Salta, Argentina
| | - José Ovelar
- Colegio Argentino de Cirugía Venosa y Linfática (CACVYL), Buenos Aires, Argentina
| | - Luis Parrotta
- Colegio Argentino de Cirugía Venosa y Linfática (CACVYL), Buenos Aires, Argentina
| | - Jorge Fernandez
- Sociedad Argentina de Flebología y Linfología (SAFYL), Buenos Aires, Argentina
| | - Miguel Avramovic
- Sociedad Argentina de Flebología y Linfología (SAFYL), Buenos Aires, Argentina
| | - Jorge Ríos
- Sociedad de Enfermedades Vasculares de Río Cuarto, Río Cuarto, Argentina
| | - Alexis Esposito
- Sociedad de Flebología y Linfología Bonaerense (SFLB), Buenos Aires, Argentina
| | - Hector Alfonso
- Sociedad de Flebología y Linfología del Nordeste (SFYLNE), Sarmiento, Argentina
| | - Emilio Desjardins
- Sociedad Tucumana de Flebología y Linfología, San Miguel de Tucumán, Argentina
| | - Luis Arias
- Comunidad Científica Boliviana de Flebología y Linfología (COBOFLIN), La Paz, Bolivia
| | - Edwaldo Joviliano
- Sociedad Brasileña de Angiología y Cirugía Vascular, Goiânia, Brazil
| | | | | | - Alvaro Orrego
- Fundación Chilena de Flebología y Linfología, Santiago del Chile, Chile
| | - Juan Bombín
- Sociedad Chilena de Flebología y Linfología (SOCHIFYL), Santiago del Chile, Chile
| | - Ismael Pizarro
- Sociedad Chilena de Flebología y Linfología (SOCHIFYL), Santiago del Chile, Chile
| | - Javier Cabezas
- Asociación de Cirujanos Vasculares Periféricos de Costa Rica, Ajuela, Costa Rica
| | - Rafael Manosalvas
- Sociedad Ecuatoriana de Flebolinfología y Microcirculación (SEFMi), Quito, Ecuador
| | - Victor Villota
- Sociedad Ecuatoriana de Flebolinfología y Microcirculación (SEFMi), Quito, Ecuador
| | - Luis Rodriguez
- Asociación Flebologica y Terapia Endovascular de El Salvador (AFLEBOVASAL), San Salvador, El Salvador
| | - Alberto Martínez Granados
- Asociación Flebologica y Terapia Endovascular de El Salvador (AFLEBOVASAL), San Salvador, El Salvador
| | - José Mérida
- Asociación Guatemalteca de Flebología (ASOFLEGUA), Ciudad de Guatemala, Guatemala
| | | | - Javier Serralde
- Academia Mexicana de Flebología y Linfología (AMFYL), Ciudad de México, Mexico
| | | | - Eloy Teixeira
- Sociedad Paraguaya de Cirugía Vascular y Angiología, Asunción, Paraguay
| | - Roberto Filizzola
- Sociedad Paraguaya de Cirugía Vascular y Angiología, Asunción, Paraguay
| | - Roberto Corbeta
- Sociedad Paraguaya de Flebología y Linfología (SPFL), Asunción, Paraguay
| | - Roy Benito
- Sociedad Peruana de Flebología y Linfología, Lima, Perú
| | | | - Tomás Rivera
- Sociedad Dominicana de Cirugía Vascular y Endovascular, Santo Domigo, República Dominicana
| | - Mauricio Volpi
- Sociedad Uruguaya de Cirugía Vascular y Endovascular (SUCIVE), Montevideo, Uruguay
| | - Sebastián Sarutte
- Sociedad Uruguaya de Cirugía Vascular y Endovascular (SUCIVE), Montevideo, Uruguay
| | - Paola Ortiz
- Sociedad Uruguaya de Flebología y Linfología (SUFYL), Montevideo, Uruguay
| | - Alfredo Prego
- Sociedad Uruguaya de Flebología y Linfología (SUFYL), Montevideo, Uruguay
| | - Hugo Navas
- Sociedad Venezolana de Flebología y Linfología, Caracas, Venezuela
| | - Tomás Alberti
- Asociación Internacional de Diagnóstico Vascular no Invasivo (ADIVANI), Bogota, Colombia
| | - Daniel Guglielmone
- Asociación Internacional de Diagnóstico Vascular no Invasivo (ADIVANI), Bogota, Colombia
| | - Raúl Mejía
- Asociación Internacional de Diagnóstico Vascular no Invasivo (ADIVANI), Bogota, Colombia
| | - Carlos Simkin
- Forum Venoso Latinoamericano, Buenos Aires, Argentina
| | - Ernesto Intriago
- Sociedad Panamericana de Flebología y Linfología, Guayaquil, Ecuador
| | - Juan Bercovich
- Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
13
|
Elias E, Savoy HM, Swanson DA, Cohnstaedt LW, Peters DPC, Derner JD, Pelzel‐McCluskey A, Drolet B, Rodriguez L. Landscape dynamics of a vector‐borne disease in the western
US
: How vector–habitat relationships inform disease hotspots. Ecosphere 2022. [DOI: 10.1002/ecs2.4267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Affiliation(s)
- Emile Elias
- US Department of Agriculture, Agricultural Research Service Jornada Experimental Range Unit Las Cruces New Mexico USA
| | - Heather M. Savoy
- US Department of Agriculture, Agricultural Research Service, Big Data Initiative and the SCINet Program for Scientific Computing Office of National Programs Beltsville Maryland USA
| | - Dustin A. Swanson
- US Department of Agriculture, Agricultural Research Service, Arthropod‐Borne Animal Diseases Research Unit Center for Grain and Animal Health Research Manhattan Kansas USA
| | - Lee W. Cohnstaedt
- US Department of Agriculture, Agricultural Research Service, Arthropod‐Borne Animal Diseases Research Unit Center for Grain and Animal Health Research Manhattan Kansas USA
| | - Debra P. C. Peters
- US Department of Agriculture, Agricultural Research Service, Big Data Initiative and the SCINet Program for Scientific Computing Office of National Programs Beltsville Maryland USA
| | - Justin D. Derner
- US Department of Agriculture, Agricultural Research Service Rangeland Resources and Systems Research Unit Cheyenne Wyoming USA
| | - Angela Pelzel‐McCluskey
- US Department of Agriculture, Animal and Plant Health Inspection Service Veterinary Services Fort Collins Colorado USA
| | - Barbara Drolet
- US Department of Agriculture, Agricultural Research Service, Arthropod‐Borne Animal Diseases Research Unit Center for Grain and Animal Health Research Manhattan Kansas USA
| | - Luis Rodriguez
- US Department of Agriculture, Agricultural Research Service Foreign Animal Disease Research Unit, Plum Island Animal Disease Center Orient Point New York USA
| |
Collapse
|
14
|
Katzen J, Rodriguez L, Tomer Y, Babu A, Zhao M, Murthy A, Carson P, Barrett M, Basil MC, Carl J, Leach JP, Morley M, McGraw MD, Mulugeta S, Pelura T, Rosen G, Morrisey EE, Beers MF. Disruption of proteostasis causes IRE1 mediated reprogramming of alveolar epithelial cells. Proc Natl Acad Sci U S A 2022; 119:e2123187119. [PMID: 36252035 PMCID: PMC9618079 DOI: 10.1073/pnas.2123187119] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Accepted: 08/20/2022] [Indexed: 02/04/2023] Open
Abstract
Disruption of alveolar type 2 cell (AEC2) protein quality control has been implicated in chronic lung diseases, including pulmonary fibrosis (PF). We previously reported the in vivo modeling of a clinical surfactant protein C (SP-C) mutation that led to AEC2 endoplasmic reticulum (ER) stress and spontaneous lung fibrosis, providing proof of concept for disruption to proteostasis as a proximal driver of PF. Using two clinical SP-C mutation models, we have now discovered that AEC2s experiencing significant ER stress lose quintessential AEC2 features and develop a reprogrammed cell state that heretofore has been seen only as a response to lung injury. Using single-cell RNA sequencing in vivo and organoid-based modeling, we show that this state arises de novo from intrinsic AEC2 dysfunction. The cell-autonomous AEC2 reprogramming can be attenuated through inhibition of inositol-requiring enzyme 1 (IRE1α) signaling as the use of an IRE1α inhibitor reduced the development of the reprogrammed cell state and also diminished AEC2-driven recruitment of granulocytes, alveolitis, and lung injury. These findings identify AEC2 proteostasis, and specifically IRE1α signaling through its major product XBP-1, as a driver of a key AEC2 phenotypic change that has been identified in lung fibrosis.
Collapse
Affiliation(s)
- Jeremy Katzen
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | - Luis Rodriguez
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | - Yaniv Tomer
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | - Apoorva Babu
- Penn-Children's Hospital of Philadelphia Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, 19104
- Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA, 19104
| | - Ming Zhao
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | - Aditi Murthy
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | - Paige Carson
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | - Matthew Barrett
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | - Maria C Basil
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | - Justine Carl
- Penn-Children's Hospital of Philadelphia Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, 19104
- Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA, 19104
| | - John P Leach
- Penn-Children's Hospital of Philadelphia Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, 19104
- Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA, 19104
| | - Michael Morley
- Penn-Children's Hospital of Philadelphia Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, 19104
- Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA, 19104
| | - Matthew D McGraw
- Division of Pulmonology, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, 14642
| | - Surafel Mulugeta
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
| | | | | | - Edward E Morrisey
- Penn-Children's Hospital of Philadelphia Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, 19104
- Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA, 19104
| | - Michael F Beers
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA,19104
- Penn-Children's Hospital of Philadelphia Lung Biology Institute, University of Pennsylvania, Philadelphia, PA, 19104
- Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, PA, 19104
| |
Collapse
|
15
|
Flores J, Moreno C, Moriarty A, Papadopoulos K, Drengler R, Rodriguez L, Salih H, Rasco D, Patnaik A, Wick M. Establishment and characterization of HPV+ metastatic squamous cell anal carcinoma XPDX models in athymic nude mice. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00837-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
16
|
Melot B, Amsilli M, Drouet F, Rodriguez L, Salomon J, Grosjean J, Duclos C. Appropriateness of Antibiotic Prescription During Teleconsultation. Stud Health Technol Inform 2022; 298:142-146. [PMID: 36073473 DOI: 10.3233/shti220924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Teleconsultation has become a new means of using care which has taken off significantly since the COVID crisis, The pooling of the technological environment within the TC makes it possible to set up practice reviews by reusing the data collected. Our aim was to evaluate the relevance of antibiotic therapy during teleconsultations carried out on the national teleconsultation platform "Qare" in 4 common infections. 143,428 TCs with structured prescriptions were analyzed, with an appropriate prescription in more than 82% of cases, higher than in the literature. The use of data makes it possible to quickly assess practices and inform doctors to improve their practices.
Collapse
Affiliation(s)
- B Melot
- Qare, Paris, France
- Université Sorbonne Paris Nord, Laboratoire d'Informatique Médicale et d'Ingénierie des connaissances en e-Santé, LIMICS, Sorbonne Université, INSERM, F-93000, Bobigny, France
| | | | | | | | | | - J Grosjean
- Université Sorbonne Paris Nord, Laboratoire d'Informatique Médicale et d'Ingénierie des connaissances en e-Santé, LIMICS, Sorbonne Université, INSERM, F-93000, Bobigny, France
- Department of Digital Health, Rouen University Hospital, Rouen France
| | - C Duclos
- Université Sorbonne Paris Nord, Laboratoire d'Informatique Médicale et d'Ingénierie des connaissances en e-Santé, LIMICS, Sorbonne Université, INSERM, F-93000, Bobigny, France
| |
Collapse
|
17
|
Zhang K, Pinto A, Cheng LY, Song P, Dai P, Wang M, Rodriguez L, Weller C, Zhang DY. Hairpin Structure Facilitates Multiplex High-Fidelity DNA Amplification in Real-Time Polymerase Chain Reaction. Anal Chem 2022; 94:9586-9594. [PMID: 35749270 DOI: 10.1021/acs.analchem.2c00575] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Clinically and biologically, it is essential to detect rare DNA-sequence variants for early cancer diagnosis or drug-resistance mutation identification. Some of the common quantitative polymerase chain reaction (qPCR)-based variant detection methods are restricted in the limit of detection (LoD) because the DNA polymerases used for these methods have a high polymerase misincorporation rate; thus, the detection sensitivity is sometimes unsatisfactory. With the proofreading activity, high-fidelity (HiFi) DNA polymerases have a 50- to 250-fold higher fidelity. However, there are currently no proper probe-based designs functioning as the fluorescence indicator allowing multiplexed HiFi qPCR reactions, thus restricting the application of HiFi DNA polymerases like the variant detection. We presented the occlusion system, composed of a 5'-overhanged primer with a fluorophore modification and a probe with a short-stem hairpin and a 3' quencher modification. We demonstrated that the occlusion system allowed multiplexing HiFi qPCR reaction, and it was compatible with the current variant-enrichment method to improve the LoD up to 10-fold. Thus, the occlusion system satisfactorily functioned as an efficient fluorescence indicator in HiFi qPCR reactions and allowed the application of HiFi DNA polymerases in variant detection methods to improve detection sensitivity.
Collapse
Affiliation(s)
- Kerou Zhang
- Department of Bioengineering, Rice University, Houston, Texas 77030, United States
| | - Alessandro Pinto
- NuProbe USA, 2575 W Bellfort Street, Houston, Texas 77054, United States
| | - Lauren Yuxuan Cheng
- Department of Bioengineering, Rice University, Houston, Texas 77030, United States
| | - Ping Song
- Department of Bioengineering, Rice University, Houston, Texas 77030, United States
| | - Peng Dai
- Department of Bioengineering, Rice University, Houston, Texas 77030, United States
| | - Michael Wang
- Department of Bioengineering, Rice University, Houston, Texas 77030, United States
| | - Luis Rodriguez
- NuProbe USA, 2575 W Bellfort Street, Houston, Texas 77054, United States
| | - Cailin Weller
- NuProbe USA, 2575 W Bellfort Street, Houston, Texas 77054, United States
| | - David Yu Zhang
- Department of Bioengineering, Rice University, Houston, Texas 77030, United States.,Systems, Synthetic, and Physical Biology, Rice University, Houston, Texas 77030, United States
| |
Collapse
|
18
|
Gordillo Montaño M, Boned Torres S, Rodriguez L. Psycho-Covid. Eur Psychiatry 2022. [PMCID: PMC9568099 DOI: 10.1192/j.eurpsy.2022.1353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction The COVID-19 pandemic generated a health emergency and led to the adoption of different measures, including home quarantine and social isolation, which, as we have seen, has had an impact on the mental health of the majority of citizens, with the possibility of psychiatric disorders appearing. in people without prior mental illness, such as acute decompensations in patients with known disorders, more vulnerable to environmental stressors. Objectives Learn and rethink alarm signals in extreme situations such as the one experienced in recent months, as well as observe the impact, negative in many cases, but positive in others, of the patients we treat daily. Methods Description through brief clinical cases of the impact of the COVID-19 pandemic on psychotic patients and the decompensation that it has entailed, including due to confinement measures and social isolation, associated with over-information through the media, chaos initial and the uncertainty that it caused and the associated fear. Results Restrictions as a result of COVID-19 have played a very relevant role as an external stressor for the appearance of psychopathological alterations, including psychotic symptoms. In addition, people who suffer from psychosis or at risk of psychotic disorder can be especially affected and trigger acute psychopathology with social isolation, loss of daily routines, unemployment, homelessness. Conclusions These cases are an example that shows the need for an early and effective approach to the rise in mental illnesses in circumstances of this caliber. Disclosure No significant relationships.
Collapse
|
19
|
Pavía Pascual M, Pérez S, Rodriguez L, Ruiz Antorán B, Rusinovich O, de la Torre Rubio N, Machattou M, Navarro Palomo P, Campos Esteban J, Fernandez Castro M, Godoy H, Barbadillo Mateos C, Merino Argumánez C, Espinosa M, Garcia-Magallon B, Calleja Panero JL, Andréu Sánchez JL, Sanz J. AB0802 PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, AND PSORIATIC ARTHRITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.2043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundNon-alcoholic fatty liver disease (NAFLD), the most common cause of liver disease, has a prevalence of about 25% in the general population. It increases mortality and comorbidity in patients with immune-mediated inflammatory diseases.ObjectivesThe main objective is to estimate the prevalence of NAFLD in three of the most common rheumatologic pathologies: rheumatoid arthritis (RA), axial spondyloarthritis (SpA-ax) and psoriatic arthritis (PsA). As a secondary objective, the possibility of finding associated risk factors in this group of subjects that may imply a higher risk of developing NAFLD is proposed.MethodsWe conducted a prospective single center observational study which included patients diagnosed with RA, EspA-ax, and PsA attended in the Rheumatology department of a tertiary hospital from January to April 2021. Anthropometric parameters, history related to cardiovascular risk factors and disease activity at the time of the visit were collected. Additionally, blood tests and transitional elastography were performed in all patients and the presence of NAFLD was assessed by the fatty liver index (FLI) scale. Different variables were considered to study their association with NAFLD.Results90 patients were included: 28 diagnosed with RA, 36 with EspA-ax and 26 with PAs. 41.1% were male (age range: 27-79 years). Patients with previous liver disease were excluded from the study. 22 (27.2%) patients had NAFLD measured by FLI ≥ 60. No significant differences in prevalence of hepatic steatosis were found between the 3 groups, although values were higher in patients with PsA.The variables that were significantly associated with the development of NAFLD in our cohort were: body mass index (BMI), abdominal perimeter, blood glucose level, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), HDL, TG, GGT, ferritin and uric acid levels. The rest of the variables studied did not show statistically significant differences (Table 1).Table 1.NO STEATOSIS (FLI<60)n=59STEATOSIS (FLI>60)n=22MeanStandard deviationMeanStandard deviationpBMI24,523,0030,292,77< 0,001Abdominal perimeter86,3410,01106,828,55< 0,001Age52,9312,8757,598,240,1185Glucose78,648,3790,6419,690,0002Insulin8,8310,1212,406,660,1302HOMA1,752,022,761,700,0500HbA1c5,350,455,690,640,0096Total cholesterol190,9829,46201,4138,530,1977HDL64,8817,6655,5911,550,0249LDL110,4428,45120,0036,210,2163TG81,1232,42128,5055,52< 0,001GPT25,8330,7337,1819,820,1116GOT27,2023,4926,8210,690,9413GGT20,8017,6649,9538,46< 0,001Creatinin0,750,190,840,180,0583Uric acid4,781,305,911,140,0007Ferritina121,75111,30208,00140,170,0050PCR2,894,552,672,330,8307ConclusionHepatic steatosis was present in 27.2% of patients vs 25% estimated prevalence in the general population. Identification of risk factors involved would allow better control of the comorbidities associated with NAFLD.The fact that the prevalence found in our sample population is so close to that of the general population, may be related to a good inflammatory control of the underlying disease.Further prospective studies with larger sample sizes are needed to find additional predictive factors for the development of NAFLD in this group of diseases.References[1]Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A. y Tiribelli, C. (2006). The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology, 6: 33.[2]Brenner, C., Galluzzi, L., Kepp, O. y Kroemer, G. (2013). Decoding cell death signals in liver inflammation. Journal of Hepatology, 59(3): 583-594.[3]Byrne, C.D. y Targher, G. (2015). NAFLD: a multisystem disease. Journal of Hepatology, 62(1 Suppl): 47[4]Miele, L., Vallone, S., Cefalo, C., La Torre, G., Di Stasi, C., Vecchio, F.M., et al. (2009). Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. Journal of Hepatology, 51(4): 778-786.Disclosure of InterestsNone declared
Collapse
|
20
|
Katzen J, Rodriguez L, Tomer Y, Babu A, Zhao M, Murthy A, Morley M, Mulugeta S, Pelura T, Rosen G, Beers MF. Disruption of Proteostasis Causes IRE1 Mediated Reprogramming of Alveolar Epithelial Cells in Lung Fibrosis. FASEB J 2022. [DOI: 10.1096/fasebj.2022.36.s1.r3918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Jeremy Katzen
- Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| | - Luis Rodriguez
- Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| | - Yaniv Tomer
- Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| | - Apoorva Babu
- Penn‐CHOP Lung Biology InstituteUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| | - Ming Zhao
- Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| | - Aditi Murthy
- Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| | - Michael Morley
- Penn‐CHOP Lung Biology InstituteUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| | - Surafel Mulugeta
- Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| | | | | | - Michaell F. Beers
- Department of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA
- University of Pennsylvania Perelman School of MedicinePhiladelphiaPA
| |
Collapse
|
21
|
Nuñez DF, Leon L, Garcia AM, Arce JIC, Mucientes A, Gutierrez-Fernandez B, Rodriguez L, Cristóbal IPS, Álvarez P, Prada CM, Abasolo L. Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study. Ther Adv Musculoskelet Dis 2022; 14:1759720X221090296. [PMID: 35510167 PMCID: PMC9058342 DOI: 10.1177/1759720x221090296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Accepted: 03/10/2022] [Indexed: 01/08/2023] Open
Abstract
Objectives The aim of this study was to assess the cause-specific mortality rate related to COVID-19 (CMR) in patients with rheumatic and musculoskeletal diseases (RMDs) and COVID-19 and to analyze the role of the different RMDs in their mortality risk. Methods An observational longitudinal study was conducted during the first pandemic wave in our center. Patients with the diagnosis of RMDs and COVID-19 were included. Main outcome is the death related to COVID-19. Independent variable - type of RMDs: autoimmune rheumatic diseases (ARD), such as chronic inflammatory arthritis (CIA) and connective tissue diseases (CTD) and non-autoimmune Rheumatic Diseases (non-ARD). Survival techniques were used to estimate the CMR per 1000 patients-month with a 95% confidence interval (CI), and Cox multivariate regression analysis was run to examine the effect of ARD compared to non-ARD on mortality risk adjusted by confounders. Results were expressed by Hazard Ratio (HR) and CI. Results Overall, 405 patients were included (642.5 patients-month). During the study period, 44 (10.86%) deaths were recorded. CMR was 68.48 (50.96-92.01). After adjusting for confounders, HR of mortality in ARD compared to non-ARD did not achieve statistical significance [HR: 1.15 (0.64-2.07)], neither CTD versus CIA nor CTD versus non-ARD. Age and certain comorbidities which are being diagnosed in March compared to April or May [HR: 2.43 (1.1-5.55)] increased the mortality risk. Glucocorticoids and disease-modifying antirheumatic drugs (DMARDs) dropped from the final model. Conclusion In patients with RMDs and COVID-19, CMR was 6.8% patients-month. This study shows that mortality risk is higher in males, older patients, and similar between CTD, CIA, and non-ARD. COVID-19 management improved after the first month of pandemic. Plain Language Summaries Mortality related to the outbreak of COVID-19 in patients with rheumatic and musculoskeletal diseases Why was this study done? - To report the COVID-19-specific mortality rate in patients with a variety of RMDs during the first pandemic peak in a tertiary hospital in Madrid and to analyze the role of specific types of ARD and other possible factors in the risk of death related to COVID-19. What did the researchers do? - We performed a retrospective observational study during the first wave of the COVID-19 pandemic in Madrid, Spain. What did the researchers find? - In this study, neither the different diagnoses of RMDs, including CIA, CTD, or non-ARD disease or its treatment were not implicated as a potential risk of death related to COVID-19- In consonance with other studies, RMDs patients and COVID-19, older age, male sex, and certain comorbidities implied more mortality risk- Our data reflect COVID-19 severity in a particular context, time, and population. In times of the absence of COVID-19 vaccine, healthcare, social, and political measures taken to contain the coronavirus outbreak have worked properly. What do the findings mean? - The presence of comorbidities in RMDs patients represents a greater risk than the different types of RMDs themselves, in the development of COVID-19 fatal outcome. It is important to integrate the control of comorbidities in the daily management.
Collapse
Affiliation(s)
| | - Leticia Leon
- Health Research Institute (IdISSC), Hospital Clínico San Carlos, c\Prof. Martín Lagos s/n, 28040 Madrid, Spain
- Health Sciences, Camilo Jose Cela University, Madrid, Spain
| | | | | | - Arkaitz Mucientes
- Health Research Institute (IdISSC), Hospital Clínico San Carlos, Madrid, Spain
| | | | - Luis Rodriguez
- Rheumatology Department, and Health Research Institute (IdISSC), Hospital Clínico San Carlos, Madrid, Spain
| | | | - Paula Álvarez
- Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain
| | | | - Lydia Abasolo
- Health Research Institute (IdISSC), Hospital Clínico San Carlos, Madrid, Spain
| |
Collapse
|
22
|
Cabang A, Moreno C, Flores JR, Boedeker J, Simonson A, Ma J, Lang A, Rodriguez G, Rosenthal A, Papadopoulos K, Patnaik A, Rasco D, Smith L, Beeram M, Drengler R, Rodriguez L, Abbate S, Ulmer S, Wick MJ. Abstract P5-01-11: Nonclinical activity of fulvestrant in a panel of ER+ breast XPDX models representing clinically acquired and innate resistance to endocrine therapies. Cancer Res 2022. [DOI: 10.1158/1538-7445.sabcs21-p5-01-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Fulvestrant is a selective estrogen receptor modulator (SERM) approved as a single agent for estrogen receptor positive, HER2 negative breast cancer patients at various stages of disease and in combination with CDK4/6 inhibitors following endocrine therapy failure. Although this agent requires intramuscular injection, it has demonstrated superior activity and fewer side effects versus some oral endocrine treatments however, resistance to fulvestrant often develops. To better understand fulvestrant resistance and its utility in patients who have failed other endocrine therapies, we evaluated the agent in a panel of ER+ breast models established from patients at various stages of disease representing endocrine-sensitive and -resistant disease. Methods: Sixty-five previously developed ER+ breast XPDX models were evaluated in this study. Models were grown subcutaneously in female athymic nude mice supplemented with estradiol in drinking water when necessary. All models were characterized at early and late passages for estrogen receptor expression by immunohistochemistry and profiled using WES and RNAseq. For in vivo studies, fulvestrant was administered by subcutaneous injection at 2.5 or 5 mg per dose once weekly until study completion. In vivo study endpoints included tumor volume and time from treatment initiation with %T/C values and tumor regression reported at study completion; a %T/C of ≤ 20 versus control was considered sensitive. Tumor regression (%T/C<0) versus Day 0 tumor volume was also reported. Models were grouped by patient clinical treatment prior to sample collection and model establishment including chemo-naïve, endocrine therapies other than fulvestrant, non-endocrine therapies, and fulvestrant. Results: All models retained ER expression in evaluated passages with similar histology compared with archival clinical samples. DNA/RNA sequencing identified several model-specific variants including ESR1 point mutations and fusions. In this study, 22% of models represented chemo-naïve patients, 24% were from patients treated with non-endocrine therapies, 20% were from patients treated with fulvestrant and the remaining 34% from patients treated with endocrine therapies other than fulvestrant. In vivo, 40% of the chemo-naïve group reported sensitivity to fulvestrant including several models with tumor regressions. Activity of fulvestrant was reported in 25% of models in the non-endocrine therapies group and in 20% of models from patients treated with either fulvestrant or endocrine therapies other than fulvestrant. Several models resistant to fulvestrant from chemo-naïve or patients treated with non-endocrine therapies harbored driver mutations including ESR1, PIK3CA, and AKT1 variants or were HER2+. In models from patients pretreated with fulvestrant, those who had also received a CDK4/6 inhibitor were particularly resistant. Conclusion: We evaluated fulvestrant in a panel of ER+ breast XPDX models representing endocrine-sensitive and -resistant disease from both chemo-naïve and pretreated patients, and identified models responsive and resistant to fulvestrant therapy. This panel can be utilized as a valuable tool in better understanding fulvestrant and endocrine therapy resistance and in developing novel therapies for patients resistant to currently available hormonal therapies.
Citation Format: April Cabang, Crystal Moreno, Johnnie R Flores, Jenna Boedeker, Alyssa Simonson, Jun Ma, Amy Lang, Gladys Rodriguez, Arthur Rosenthal, Kyriakos Papadopoulos, Amita Patnaik, Drew Rasco, Lon Smith, Murali Beeram, Ronald Drengler, Luis Rodriguez, Steven Abbate, Scott Ulmer, Michael J Wick. Nonclinical activity of fulvestrant in a panel of ER+ breast XPDX models representing clinically acquired and innate resistance to endocrine therapies [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P5-01-11.
Collapse
Affiliation(s)
| | | | | | | | | | - Jun Ma
- XenoSTART, San Antonio, TX
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Hider R, Kleissas D, Gion T, Xenes D, Matelsky J, Pryor D, Rodriguez L, Johnson EC, Gray-Roncal W, Wester B. The Brain Observatory Storage Service and Database (BossDB): A Cloud-Native Approach for Petascale Neuroscience Discovery. Front Neuroinform 2022; 16:828787. [PMID: 35242021 PMCID: PMC8885591 DOI: 10.3389/fninf.2022.828787] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2021] [Accepted: 01/10/2022] [Indexed: 12/04/2022] Open
Abstract
Technological advances in imaging and data acquisition are leading to the development of petabyte-scale neuroscience image datasets. These large-scale volumetric datasets pose unique challenges since analyses often span the entire volume, requiring a unified platform to access it. In this paper, we describe the Brain Observatory Storage Service and Database (BossDB), a cloud-based solution for storing and accessing petascale image datasets. BossDB provides support for data ingest, storage, visualization, and sharing through a RESTful Application Programming Interface (API). A key feature is the scalable indexing of spatial data and automatic and manual annotations to facilitate data discovery. Our project is open source and can be easily and cost effectively used for a variety of modalities and applications, and has effectively worked with datasets over a petabyte in size.
Collapse
|
24
|
Zhang K, Rodriguez L, Cheng LY, Wang M, Zhang DY. Single-Tube qPCR Detection and Quantitation of Hotspot Mutations Down to 0.01% Variant Allele Fraction. Anal Chem 2021; 94:934-943. [PMID: 34932306 DOI: 10.1021/acs.analchem.1c03716] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Clinically and biologically, rare DNA sequence variants are significant and informative. However, existing common detection technologies are either complex and time-consuming in workflow, or restricted in the limit of detection (LoD), or do not allow for multiplexing. Blocker displacement amplification (BDA) method can stably and effectively detect and enrich multiple rare variants with LoD around 0.1% variant allele fraction (VAF). Nonetheless, the detailed mutation information has to be identified by additional sequencing technologies. Here, we present allele-specific BDA (As-BDA), a method combining BDA with allele-specific TaqMan (As-TaqMan) probes for effective variant enrichment and simultaneous single nucleotide variant or small insertions and deletions (INDELs) profiling. We demonstrated that As-BDA could detect mutations down to 0.01% VAF. Further, As-BDA could detect up to four mutations with low to 0.1% VAF per reaction using only 15 ng DNA input. The median error of As-BDA in VAF determination is approximately 9.1%. Comparison experiments using As-BDA and droplet digital PCR on peripheral blood mononuclear cell clinical samples showed 100% concordance for samples with mutations at ≥ 0.1% VAF. Hence, we have shown that As-BDA can achieve simultaneous enrichment and identification of multiple targeted mutations within the same reaction with high clinical sensitivity and specificity, thus helpful for clinical diagnosis.
Collapse
Affiliation(s)
- Kerou Zhang
- Bioengineering, Rice University, Houston, Texas 77030, United States
| | | | | | - Michael Wang
- Bioengineering, Rice University, Houston, Texas 77030, United States
| | | |
Collapse
|
25
|
Emenaker N, Rodriguez L. Incorporating Dietary Supplement Use into Client Care Practices: An Oncology Example. J Acad Nutr Diet 2021. [DOI: 10.1016/j.jand.2021.06.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
26
|
Hua HU, Martens R, Read SP, Cernichiaro-Espinosa LA, Fallas B, Oliver AL, Younis R, Rodriguez L, Berrocal AM. Neurofibromatosis type 1 presenting with retinal detachment and laryngeal plexiform neurofibroma in a toddler. Am J Ophthalmol Case Rep 2021; 23:101170. [PMID: 34381922 PMCID: PMC8332657 DOI: 10.1016/j.ajoc.2021.101170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2020] [Revised: 04/10/2021] [Accepted: 07/19/2021] [Indexed: 12/03/2022] Open
Abstract
Purpose To present a 22-month-old girl with a complete retinal detachment who was found to have systemic exam findings consistent with neurofibromatosis type 1 during the course of multi-specialty exam under anesthesia. Observations During examination under anesthesia, ophthalmic exam findings demonstrated retinal detachment with cyst formation, as well as peripheral non-perfusion of the retina in the left eye. Non-ophthalmic findings discovered on difficulty with intubation included a laryngeal plexiform neurofibroma and café-au-lait spots. Conclusions Pediatric retinal detachments are uncommon compared to those in adults. Pediatric patients with neurofibromatosis type 1 can present with vision loss as the presenting symptom. Systemic signs and symptoms should be carefully screen and monitored.
Collapse
Affiliation(s)
- Hong-Uyen Hua
- Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, 900 NW 17th St Miami, FL, 33136, USA
| | - Rosanna Martens
- Department of Ophthalmology and Visual Sciences, University of British Columbia, 2550 Willow Street, Vancouver, BC, V5Z 3N9, Canada
| | - Sarah Parker Read
- Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, 900 NW 17th St Miami, FL, 33136, USA
| | - Linda A Cernichiaro-Espinosa
- Asociación Para Evitar La Ceguera en México, IAP, Vicente García Torres 46, Colonia Barrio San Lucas, Coyoacán, Ciudad de México, C.P 04030, Mexico
| | - Brenda Fallas
- Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, 900 NW 17th St Miami, FL, 33136, USA
| | - Armando L Oliver
- Department of Ophthalmology, University of Puerto Rico, Medical Sciences Campus, PO BOX 365067, San Juan, 00936-5067, Puerto Rico
| | - Ramzi Younis
- Bascom Palmer Eye Institute, Department of Otolaryngology, University of Miami Miller School of Medicine, 900 NW 17th St, Miami, FL, 33136, USA
| | - Luis Rodriguez
- Department of Anesthesiology, University of Miami Miller School of Medicine, 1611 NW 12th Ave (C-301), Miami, FL, 33136, USA
| | - Audina M Berrocal
- Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, 900 NW 17th St Miami, FL, 33136, USA
| |
Collapse
|
27
|
Abstract
The main goal of this paper is to outline a new optimization algorithm based on String Theory, which is a relative new area of physics. The String Theory Algorithm (STA) is a nature-inspired meta-heuristic, which is based on studies about a theory stating that all the elemental particles that exist in the universe are strings, and the vibrations of these strings create all particles existing today. The newly proposed algorithm uses equations based on the laws of physics that are stated in String Theory. The main contribution in this proposed method is the new techniques that are devised in order to generate potential solutions in optimization problems, and we are presenting a detailed explanation and the equations involved in the new algorithm in order to solve optimization problems. In this case, we evaluate this new proposed meta-heuristic with three cases. The first case is of 13 traditional benchmark mathematical functions and a comparison with three different meta-heuristics is presented. The three algorithms are: Flower Pollination Algorithm (FPA), Firefly Algorithm (FA) and Grey Wolf Optimizer (GWO). The second case is the optimization of benchmark functions of the CEC 2015 Competition and we are also presenting a statistical comparison of these results with respect to FA and GWO. In addition, we are presenting a third case, which is the optimization of a fuzzy inference system (FIS), specifically finding the optimal design of a fuzzy controller, where the main goal is to optimize the membership functions of the FIS. It is important to mention that we used these study cases in order to analyze the proposed meta-heuristic with: basic problems, complex problems and control problems. Finally, we present the performance, results and conclusions of the new proposed meta-heuristic.
Collapse
Affiliation(s)
- Luis Rodriguez
- Tijuana Institute of Technology, Calzada Tecnologico s/n, Frac. Tomas Aquino, Tijuana, Mexico
| | - Oscar Castillo
- Tijuana Institute of Technology, Calzada Tecnologico s/n, Frac. Tomas Aquino, Tijuana, Mexico
| | - Mario Garcia
- Tijuana Institute of Technology, Calzada Tecnologico s/n, Frac. Tomas Aquino, Tijuana, Mexico
| | - Jose Soria
- Tijuana Institute of Technology, Calzada Tecnologico s/n, Frac. Tomas Aquino, Tijuana, Mexico
| |
Collapse
|
28
|
Pelzel-McCluskey A, Christensen B, Humphreys J, Bertram M, Keener R, Ewing R, Cohnstaedt LW, Tell R, Peters DPC, Rodriguez L. Review of Vesicular Stomatitis in the United States with Focus on 2019 and 2020 Outbreaks. Pathogens 2021; 10:993. [PMID: 34451457 PMCID: PMC8399664 DOI: 10.3390/pathogens10080993] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Revised: 08/02/2021] [Accepted: 08/04/2021] [Indexed: 12/05/2022] Open
Abstract
Vesicular stomatitis (VS) is a vector-borne livestock disease caused by vesicular stomatitis New Jersey virus (VSNJV) or vesicular stomatitis Indiana virus (VSIV). The disease circulates endemically in northern South America, Central America, and Mexico and only occasionally causes outbreaks in the United States. Over the past 20 years, VSNJV outbreaks in the southwestern and Rocky Mountain regions occurred with incursion years followed by virus overwintering and subsequent expansion outbreak years. Regulatory response by animal health officials is deployed to prevent spread from lesioned animals. The 2019 VS incursion was the largest in 40 years, lasting from June to December 2019 with 1144 VS-affected premises in 111 counties in eight states (Colorado, Kansas, Nebraska, New Mexico, Oklahoma, Texas, Utah, and Wyoming) and was VSIV serotype, last isolated in 1998. A subsequent expansion occurred from April to October 2020 with 326 VS-affected premises in 70 counties in eight states (Arizona, Arkansas, Kansas, Missouri, Nebraska, New Mexico, Oklahoma, and Texas). The primary serotype in 2020 was VSIV, but a separate incursion of VSNJV occurred in south Texas. Summary characteristics of the outbreaks are presented along with VSV-vector sampling results and phylogenetic analysis of VSIV isolates providing evidence of virus overwintering.
Collapse
Affiliation(s)
- Angela Pelzel-McCluskey
- United States Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), Veterinary Services, Fort Collins, CO 80526, USA
| | | | - John Humphreys
- USDA-Agriculture Research Service (ARS), Northern Plains Agricultural Research Laboratory, Pest Management Research, Sidney, MT 59270, USA;
| | - Miranda Bertram
- USDA-ARS, Plum Island Animal Disease Center, Long Island, NY 11957, USA; (M.B.); (L.R.)
| | - Robert Keener
- Department of Agriculture, Fort Hays State University, Hays, KS 67601, USA;
| | - Robert Ewing
- USDA-ARS, Center for Grain and Animal Health Research, Arthropod-Borne Animal Diseases Research, Manhattan, KS 66502, USA; (R.E.); (L.W.C.)
| | - Lee W. Cohnstaedt
- USDA-ARS, Center for Grain and Animal Health Research, Arthropod-Borne Animal Diseases Research, Manhattan, KS 66502, USA; (R.E.); (L.W.C.)
| | - Rachel Tell
- USDA-APHIS-Veterinary Services, National Veterinary Services Laboratories, Ames, IA 50010, USA;
| | - Debra P. C. Peters
- USDA-ARS, Jornada Experimental Range Unit, Las Cruces, NM 88003, USA;
- USDA-ARS SCINet Big Data Program, Berwyn Heights, MD 20740, USA
| | - Luis Rodriguez
- USDA-ARS, Plum Island Animal Disease Center, Long Island, NY 11957, USA; (M.B.); (L.R.)
| |
Collapse
|
29
|
Linares Galiana I, Garcia Exposito N, Plana M, Brenes J, Oliva M, Nogues J, Cos M, Rodriguez L, Tornero J, Mora P, Lozano A. PO-0960 Long-term outcome of IMRT-SIB and chemotherapy in nasopharyngeal carcinoma in a nonendemic area. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07411-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
30
|
Wang T, Flamm S, Schoenhagen P, Griffin B, Rodriguez L, Grimm R, Xu B. Diagnostic And Prognostic Performance Of Aortic Valve Calcium Score By Cardiac Computed Tomography For Severe Aortic Stenosis: A Meta-analysis. J Cardiovasc Comput Tomogr 2021. [DOI: 10.1016/j.jcct.2021.06.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Pieruzzini R, Ayala-Grosso C, de Jesus Navas J, Rodriguez W, Parra N, Luque E, Sanchez-Gago A, Gonzalez S, Hagobian A, Grullon A, Diaz K, Morales M, De Jesus M, Pena S, Rodriguez L, Pena L, Asaro A, Magris M. What smell and taste disorders by SARS-CoV-2 do we know? Predictive value of the Venezuelan Olfactory Test and RT-PCR molecular analysis in COVID-19 infection. RHINOL 2021. [DOI: 10.4193/rhinol/21.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Background: Smell and taste disorders are reported very frequently and at an early stage in SARS-CoV-2 infectious disease. These symptoms could be sensitive and specific to establish possible severity of the infection, and may suggest the flow of decisions as to further therapy. Objective: We asked whether smell and taste impairment are earlier and more sensitive symptoms than the RT-PCR molecular assays for SARS-CoV-2 detection. Methods: Subjects (N=275) with a probable COVID-19 diagnosis were classified as follows: Symptomatic with chemosensory dysfunction, symptomatic without chemosensory dysfunction, and asymptomatic. Validated unbiased testing of the chemosensory dysfunction was performed by means of the Venezuelan Olfactory Test and taste test. Nasal swabs and blood samples were analyzed by RT-PCR molecular analysis a rapid diagnostic test to detect the SARS-CoV-2 virus and viral antibodies, respectively. Smell and taste testing and RT-PCR were performed every 3 to 5 days to patients until full recovery. Results: Out of 144 patients that were positive for SARS-CoV-2: 45.83% had COVID-19 symptoms, smell and taste disorders; 23.61% had COVID-19 symptoms but not smell or taste disorders, and 30.55% were asymptomatic. Mild hyposmia and hypogeusia were frequently associated with SARS-CoV-2 symptoms. Recovery from chemosensory dysfunction occurred between day 3 and 14. RT-PCR becomes negative after 21 days. The Venezuelan Olfactory Test and taste test has a 61.68% positive predictive value, 45.83% sensitivity, and 68.7% specificity for SARS-CoV-2. Conclusions: Smell and taste disorders are associated symptoms with SARS-CoV-2 infection, but not a predictor of the disease, as compared to the molecular RT-PCR test.
Collapse
|
32
|
Abstract
Birth weight discordance (BWD) is not an uncommon event in twin pregnancies and can be associated with maternal and newborn characteristics. We aimed to analyse the association between maternal sociodemographic and newborn characteristics with BWD in twin infants born in Yucatan, Mexico, during 2008-2017 (n = 2091 pairs). BWD was calculated as the percentage of birth weight of the heavier twin. We defined three categories of BWD: concordant twins: <15%, mild-discordant: 15-24%, and severe discordant: ≥25%. A multinomial logistic regression model was used to analyse the association between maternal sociodemographic and newborn characteristics with BWD. Seventy-four percent (n = 1547) of twin pairs were classified as concordant, 17% (n = 356) met the criteria for mild-discordance and 9% (n = 188) for severe discordance. The odds for mild-discordance were significantly lower for mothers with medium level of education and in the highest quartile of total twin birth weight (TBW). Opposite-sex twin pairs showed increased odds for mild-discordance compared with same-sex pairs. The odds for severe discordance increased as mothers were in older age groups and decreased as TBW increased. Our rates of BWD are similar to those reported in populations from wealthier countries and maternal age and education, infants' sex, and TBW are associated with BWD.
Collapse
Affiliation(s)
- Hugo Azcorra
- Centro de Investigaciones Silvio Zavala, Universidad Modelo, Mérida, México
| | - Luis Rodriguez
- Faculta de Matemáticas, Universidad Autónoma de Yucatán, Mérida, México
| | - Nina Méndez
- Hospital Regional de Alta Especialidad de la Península de Yucatán, Mérida, México
| |
Collapse
|
33
|
Torrents-Zapata S, Aran G, Codinach M, Blanco M, Soria G, Rodriguez L, Querol S, Vives J. Design and validation of an improved immunopotency assay for product release of mesenchymal stromals cell-based therapeutics in accordance to good manufacturing practices. Cytotherapy 2021. [DOI: 10.1016/s146532492100596x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
34
|
Rodriguez L, Katzen J, Murthy A, Tomer Y, Carson P, Dimopoulos T, Mulugeta S, Morley M, Himes B, Beers M. Warburg and Scars? Alveolar Type II Cell Glycolytic Reprogramming and Differential Mitochondrial Dynamics Observed in a Murine Model of Pulmonary Fibrosis. FASEB J 2021. [DOI: 10.1096/fasebj.2021.35.s1.02506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
35
|
Munera-Campos M, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, Sahuquillo-Torralba A, Gómez-García FJ, Baniandrés-Rodríguez O, de la Cueva P, López-Estebaranz JL, Belinchón I, Ferran M, Riera-Monroig J, Rodriguez L, Carretero G, García-Donoso C, Ballescá F, Llamas-Velasco M, Herrera-Ceballos E, Pujol-Marco C, Nieto-Benito LM, Ruiz-Genao DP, Alsina M, Descalzo MA, García-Doval I. The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry. J DERMATOL TREAT 2021; 33:2110-2117. [PMID: 33913796 DOI: 10.1080/09546634.2021.1922572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
BACKGROUND Limited information is available regarding the risk of incident liver disease in patients with psoriasis receiving systemic therapies. OBJECTIVES To describe the liver safety findings of conventional and modern systemic therapies for moderate-to-severe psoriasis, and to compare the relative incidence rates of hepatic adverse events (AEs) for each drug. METHODS All the patients on the BIOBADADERM registry were included. Crude and adjusted incidence rate ratios (cIRR and aIRR, respectively) of hepatic AEs, using anti-TNF drugs as reference, were determined. Outcomes of interest were hypertransaminasemia, nonalcoholic fatty liver disease (NADFLD) and a group of other, less represented, hepatic AEs. RESULTS Our study included 3,171 patients exposed to systemic drugs (6279 treatment cycles). Incident hypertransaminasemia was the most frequent hepatic AE (incidence rate of 21 per 1000 patients-years [CI 95% CI 18-23]), followed by NAFLD (8 cases per 1000 patients-years [95% CI 6-10]). Methotrexate (aIRR 3.06 [2.31-4.4]; p = 0.000) and cyclosporine (aIRR 2.37 [1.05-5.35]; p = 0.0378) were associated with an increased risk for hypertransaminasemia when compared to anti-TNF-α agents. No differences were observed between different groups of biologics. Conventional therapies were not associated with new incident NAFLD. CONCLUSIONS Comparative information of the incidence of hepatic AEs could facilitate drug selection in moderate-to-severe psoriasis.
Collapse
Affiliation(s)
- M Munera-Campos
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - J Vilar-Alejo
- Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
| | - R Rivera
- Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - J M Carrascosa
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - E Daudén
- Department of Dermatology. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain
| | - E Herrera-Acosta
- Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - A Sahuquillo-Torralba
- Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - F J Gómez-García
- Department of Dermatology, Hospital Universitario Reina Sofía, Cordoba, Spain
| | - O Baniandrés-Rodríguez
- Department of Dermatology, CEIMI Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - P de la Cueva
- Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain
| | - J L López-Estebaranz
- Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - I Belinchón
- Department of Dermatology, Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain
| | - M Ferran
- Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
| | - J Riera-Monroig
- Department of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona, Spain
| | - L Rodriguez
- Department of Dermatology, Hospital Virgen del Rocío, Sevilla, Spain
| | - G Carretero
- Department of Dermatology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
| | - C García-Donoso
- Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - F Ballescá
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain
| | - M Llamas-Velasco
- Department of Dermatology. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain
| | - E Herrera-Ceballos
- Department of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - C Pujol-Marco
- Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - L M Nieto-Benito
- Department of Dermatology, CEIMI Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - D P Ruiz-Genao
- Department of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - M Alsina
- Department of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona, Spain
| | - M A Descalzo
- Research Unit. Fundación Piel Sana AEDV, Madrid, Spain
| | - I García-Doval
- Research Unit. Fundación Piel Sana AEDV, Madrid, Spain.,Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain
| | | |
Collapse
|
36
|
Alexiades NG, Shao B, Braga BP, Bonfield CM, Brockmeyer DL, Browd SR, DiLuna M, Groves ML, Hankinson TC, Jea A, Leonard JR, Lew SM, Limbrick DD, Mangano FT, Martin J, Pahys J, Powers A, Proctor MR, Rodriguez L, Rozzelle C, Storm PB, Anderson RCE. Development of best practices in the utilization and implementation of pediatric cervical spine traction: a modified Delphi study. J Neurosurg Pediatr 2021; 27:649-660. [PMID: 33799292 DOI: 10.3171/2020.10.peds20778] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2020] [Accepted: 10/30/2020] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Cervical traction in pediatric patients is an uncommon but invaluable technique in the management of cervical trauma and deformity. Despite its utility, little empirical evidence exists to guide its implementation, with most practitioners employing custom or modified adult protocols. Expert-based best practices may improve the care of children undergoing cervical traction. In this study, the authors aimed to build consensus and establish best practices for the use of pediatric cervical traction in order to enhance its utilization, safety, and efficacy. METHODS A modified Delphi method was employed to try to identify areas of consensus regarding the utilization and implementation of pediatric cervical spine traction. A literature review of pediatric cervical traction was distributed electronically along with a survey of current practices to a group of 20 board-certified pediatric neurosurgeons and orthopedic surgeons with expertise in the pediatric cervical spine. Sixty statements were then formulated and distributed to the group. The results of the second survey were discussed during an in-person meeting leading to further consensus. Consensus was defined as ≥ 80% agreement on a 4-point Likert scale (strongly agree, agree, disagree, strongly disagree). RESULTS After the initial round, consensus was achieved with 40 statements regarding the following topics: goals, indications, and contraindications of traction (12), pretraction imaging (6), practical application and initiation of various traction techniques (8), protocols in trauma and deformity patients (8), and management of traction-related complications (6). Following the second round, an additional 9 statements reached consensus related to goals/indications/contraindications of traction (4), related to initiation of traction (4), and related to complication management (1). All participants were willing to incorporate the consensus statements into their practice. CONCLUSIONS In an attempt to improve and standardize the use of cervical traction in pediatric patients, the authors have identified 49 best-practice recommendations, which were generated by reaching consensus among a multidisciplinary group of pediatric spine experts using a modified Delphi technique. Further study is required to determine if implementation of these practices can lead to reduced complications and improved outcomes for children.
Collapse
Affiliation(s)
- Nikita G Alexiades
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York
| | - Belinda Shao
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York.,2Rutgers New Jersey Medical School, Newark, New Jersey
| | - Bruno P Braga
- 3Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas
| | - Christopher M Bonfield
- 4Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Douglas L Brockmeyer
- 5Department of Pediatric Neurosurgery, Primary Children's Hospital, University of Utah, Salt Lake City, Utah
| | - Samuel R Browd
- 6Department of Neurosurgery, University of Washington/Seattle Children's Hospital, Seattle, Washington
| | - Michael DiLuna
- 7Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut
| | - Mari L Groves
- 8Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Todd C Hankinson
- 9Department of Pediatric Neurosurgery, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Andrew Jea
- 10Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana
| | - Jeffrey R Leonard
- 11Department of Neurosurgery, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio
| | - Sean M Lew
- 12Department of Pediatric Neurosurgery, Children's Wisconsin, Milwaukee, Wisconsin
| | - David D Limbrick
- 13Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri
| | - Francesco T Mangano
- 14Division of Pediatric Neurosurgery, Cincinnati Children's Hospital, Cincinnati, Ohio
| | - Jonathan Martin
- 15Division of Pediatric Neurosurgery, Connecticut Children's Hospital, Hartford, Connecticut
| | - Joshua Pahys
- 16Department of Pediatric Orthopedic Surgery, Shriners Hospital for Children, Philadelphia, Pennsylvania
| | - Alexander Powers
- 17Department of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, North Carolina
| | - Mark R Proctor
- 18Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Luis Rodriguez
- 19Department of Neurosurgery, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
| | - Curtis Rozzelle
- 20Department of Neurosurgery, Division of Pediatric Neurosurgery, University of Alabama, Birmingham; and
| | - Phillip B Storm
- 21Department of Neurosurgery, University of Pennsylvania/Children's Hospital of Philadelphia, Pennsylvania
| | - Richard C E Anderson
- 1Department of Neurological Surgery, Columbia University Medical Center, New York, New York
| |
Collapse
|
37
|
Stewart S, King F, Rodriguez L, Meier S, Sherry S, Abbass A, Deacon H, Nogueira-Arjona R, Hagen A. The effects of excessive and compulsive online searching of COVID-19 information (“cyberchondria”) on general and COVID-19-specific anxiety and fear in romantic couples during lockdown. Eur Psychiatry 2021. [PMCID: PMC9471794 DOI: 10.1192/j.eurpsy.2021.792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Introduction Cyberchondria involves excessive and uncontrollable online searching of information about a perceived illness. This behavior can cause or maintain distress. Objectives Little is known about cyberchondria during the COVID-19 pandemic or how cyberchondria in one individual may cause distress in their significant other if they are self-isolating together; our study sought to fill these gaps. Methods We conducted a Qualtrics Panel survey with 760 cohabitating Canadian couples; in June 2020, participants retrospectively reported on their cyberchondria behavior, general anxiety, and COVID-19 fears during the month of April 2020, while adhering to stay-at-home advisories. Two separate actor-partner interdependence models (APIMs) used cyberchondria excessiveness and compulsion to predict generalized anxiety and COVID-19 danger/contamination fears in the actor and partner. Results Both cyberchondria excessiveness and compulsion were associated with higher general anxiety and higher COVID-19 danger/contamination fears in the individual (actor effects). Partner cyberchondria compulsion was associated with higher general anxiety in the individual whereas partner cyberchondria excessiveness was associated with higher COVID-19 danger/contamination fears in the individual (partner effects). Conclusions Findings suggest that excessive and uncontrollable searching of information about COVID-19 on the internet during lockdown may contribute to distress in both the individual engaging in the cyberchondria behavior, and in their romantic partner. Moreover, different aspects of cyberchondria in the partner (compulsion vs. excessiveness) appears to contribute to general vs. COVID-19-specific anxiety/fears in the partner, respectively. Future research should examine mechanisms underlying the observed partner effects (e.g., co-rumination, social contagion) and reasons for the differential partner effects of cyberchondria components.
Collapse
|
38
|
Veiga S, Del Cerro JS, Rodriguez L, Trinidad A, González-Ravé JM. How Mixed Relay Teams in Swimming Should Be Organized for International Championship Success. Front Psychol 2021; 12:573285. [PMID: 33716847 PMCID: PMC7943605 DOI: 10.3389/fpsyg.2021.573285] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 02/01/2021] [Indexed: 11/18/2022] Open
Abstract
The primary goal of the present research was to determine the order of swimmers on a mixed relay team that would ensure the best performance in the Fédération Internationale de Natation (FINA) World Championships held in Kazan (Russia, 2015), Budapest (Hungary, 2017), and Gwangju (South Korea, 2019). The data were obtained from database websites for the 4 × 100 m freestyle and 4 × 100 m medley official results,1 including 660 records from 188 entries of finals and 472 preliminary events. The results showed that the fastest swimmers (according to their best season times) were located primarily in the first or second positions of the freestyle relay. The most successful gender strategy for the 4 × 100 m freestyle (57 out of 82 observations) and for the 4 × 100 m medley (29 out of 83) relays was the order male-male-female-female, although no statistical differences were found (p = 0.79) for the medley relays. In the 4 × 100 m freestyle, the second (p = 0.002; β = 1.62) and third (p =0.003; β = 1.41) relay legs had a statistical effect on the total relay time, whereas in the 4 × 100 m medley, all four relay legs had a statistical effect (p < 0.001) on the final performance, the weight of the four strokes being different in heats with respect to the final round. Also, a later position of the first female swimmer or the consecutive position of two female swimmers in the team order significantly affected the relay performance in specific events. Mixed relay events appeared to present specific strategies in comparison to traditional male- or female-only relay lineups.
Collapse
Affiliation(s)
- Santiago Veiga
- Health and Human Performance Department, Universidad Politécnica de Madrid, Madrid, Spain.,Royal Spanish Swimming Federation, Madrid, Spain
| | | | | | - Alfonso Trinidad
- Faculty of Education and Humanities, Universidad Francisco de Vitoria, Madrid, Spain
| | - José María González-Ravé
- Sports Training Laboratory, Faculty of Sports Sciences, University of Castilla La Mancha, Toledo, Spain
| |
Collapse
|
39
|
Shimony N, Louie C, Barrow D, Osburn B, Noureldine MHA, Tuite GF, Carey CM, Jallo GI, Rodriguez L. Adolescent Disc Disease: Risk Factors and Treatment Success-Related Factors. World Neurosurg 2021; 148:e314-e320. [PMID: 33412329 DOI: 10.1016/j.wneu.2020.12.126] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2020] [Revised: 12/25/2020] [Accepted: 12/26/2020] [Indexed: 01/02/2023]
Abstract
OBJECTIVE A paucity of literature is available discussing the associated risk factors, treatment options (including the use of minimally invasive surgery), and outcomes related to lumbar disc herniation (LDH) in children. We have discussed the risk factors for disc disease among pediatric patients and evaluated the efficacy of the minimally invasive approach. METHODS A retrospective review of pediatric patients with lumbar disc disease who had undergone microdiscectomy at our institution from 2005 to 2016 was conducted. The preoperative presentation, hospital course, postoperative course, and follow-up data (≥3 years) were reviewed. We evaluated the risk factors for LDH and the surgical outcomes for both groups. RESULTS A total of 52 pediatric patients had undergone 61 lumbar disc surgeries for LDH in our department from 2005 to 2016. Their average age at surgery was 16.65 years. Of the 61 procedures, 48 (78.7%) had been performed via the minimally invasive spine microdiscectomy approach and 13 (21.3%) via the open microdiscectomy approach. The average body mass index for all cases was 29.3 kg/m2. The average interval to diagnosis was 7.9 months. Of the 61 cases, 21 (34.4%) had been required for patients who were competitive athletes. In addition, 15 had been for LDH related to trauma (24.6%). In 46 of the 61 cases, complete resolution of the symptoms had occurred at the 1-year follow-up visit (79.2% of minimally invasive spine microdiscectomy vs 61.5% of open microdiscectomy). CONCLUSION Risk factors similar to those for adult LDH, such as an elevated body mass index, can be seen in the pediatric population. However, some unique risk factors such as post-traumatic LDH were found in the pediatric age group. Minimally invasive techniques are demonstrably safe and useful in this patient population.
Collapse
Affiliation(s)
- Nir Shimony
- Institute for Brain Protection Sciences, All Children's Hospital, Johns Hopkins University and Medicine, St. Petersburg, Florida, USA; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Division of Pediatric Neurosurgery, Institute of Neuroscience, Geisinger Medical Center, Danville, Pennsylvania, USA; Department of Neurosurgery, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
| | - Christopher Louie
- Institute for Brain Protection Sciences, All Children's Hospital, Johns Hopkins University and Medicine, St. Petersburg, Florida, USA; Department of Neurosurgery, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA
| | - David Barrow
- Department of Neurosurgery, University of South Florida, Tampa, Florida, USA
| | - Brooks Osburn
- Department of Neurosurgery, University of South Florida, Tampa, Florida, USA
| | - Mohammad Hassan A Noureldine
- Institute for Brain Protection Sciences, All Children's Hospital, Johns Hopkins University and Medicine, St. Petersburg, Florida, USA
| | - Gerald F Tuite
- Institute for Brain Protection Sciences, All Children's Hospital, Johns Hopkins University and Medicine, St. Petersburg, Florida, USA; Department of Neurosurgery, University of South Florida, Tampa, Florida, USA
| | - Carolyn M Carey
- Institute for Brain Protection Sciences, All Children's Hospital, Johns Hopkins University and Medicine, St. Petersburg, Florida, USA; Department of Neurosurgery, University of South Florida, Tampa, Florida, USA
| | - George I Jallo
- Institute for Brain Protection Sciences, All Children's Hospital, Johns Hopkins University and Medicine, St. Petersburg, Florida, USA; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Neurosurgery, University of South Florida, Tampa, Florida, USA
| | - Luis Rodriguez
- Institute for Brain Protection Sciences, All Children's Hospital, Johns Hopkins University and Medicine, St. Petersburg, Florida, USA; Department of Neurosurgery, University of South Florida, Tampa, Florida, USA
| |
Collapse
|
40
|
Abstract
STUDY DESIGN Retrospective analysis. OBJECTIVES The objective of this study was to analyze the feasibility of correcting double-curve scoliosis using dynamic scoliosis correction (DSC, also known as vertebral body tethering), which requires a bilateral anterior approach with deflation of both lungs. Typically, this approach falls under the exclusionary criteria for the eligibility for anterior scoliosis surgery. No data exists on the feasibility of single-staged bilateral DSC. METHODS A retrospective analysis was performed utilizing the data from 25 patients who underwent a bilateral anterior thoracic approach and instrumentation. Thirty-day postoperative complication rates were analyzed. A learning curve subanalysis was also performed to compare the first 12 patients to the remainder of the 13 patients, with a T-test (P ≤ .05). RESULTS Of the 25 patients treated, there was 1 intraoperative event: After performing lumbar DSC, the contralateral DSC was abandoned due to unexpected pleural scarring and staged selective thoracic fusion was performed. We observed 4 postoperative complications: 2 patients had recurrent pleural effusions, 1 patient was diagnosed with pneumonia, and 1 patient had a minor pulmonary embolism without cardiopulmonary consequences (after an international 24 hour flight). All patients recovered well. We observed a significant influence of learning curve on surgical time (328 vs 280 min, P = .03) and blood loss (480 vs 197 mL, P = .03). CONCLUSION Data suggests that bilateral, single-stage surgery for DSC is feasible albeit with an elevated complication rate that may partially attributable to the learning curve. Future research should focus on the cause of pulmonary complications and include a matched comparative analysis with traditional posterior fusion.
Collapse
Affiliation(s)
- Alice Baroncini
- Eifelklinik St. Brigida, Abteilung für Wirbelsäulenchirurgie, Simmerath, Germany,Alice Baroncini, Eifelklinik St. Brigida, Abteilung für Wirbelsäulenchirurgie, Kammerbruchstraße 8, 52152 Simmerath, Germany.
| | | | - Kushagra Verma
- Beach Orthopaedic Specialty Institute, Los Alamitos, CA, USA
| | - Per D. Trobisch
- Eifelklinik St. Brigida, Abteilung für Wirbelsäulenchirurgie, Simmerath, Germany
| |
Collapse
|
41
|
Flores VC, Geller T, Gomez IG, Rodriguez L, Quintana J, Stapleton S. RARE-36. DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS: A REVIEW OF CLINICAL AND MOLECULAR CHARACTERISTICS, AND OUTCOME IN A PEDIATRIC POPULATION AT A SINGLE CENTER. Neuro Oncol 2020. [PMCID: PMC7715727 DOI: 10.1093/neuonc/noaa222.746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND Neuronal and mixed neuro-glial tumors of the central nervous system (CNS) are relatively rare. Dysembryoplastic neuroepithelial tumor (DNET) is a benign, rare, slow-growing tumor, but in many cases is associated with intractable epilepsy. OBJECTIVE To report the experience with DNET at a single free-standing children’s institution. METHODS A retrospective chart review of 24 patients with confirmed DNET between 2001 and 2019 was performed. Data was collected on clinical characteristics, tumor location, surgical management, histopathological and molecular findings, and outcomes. RESULTS Mean age at diagnosis was 10 years (range 2 to 19 years), with female predominance (54.2%). Most common presenting symptoms were seizures (79.2%) and headaches (12.5%). Location of the tumor was temporal (29.2%), frontal (25.0%), parietal (16.7%), cerebellar (12.5%) and occipital (4.2%). A gross total resection was achieved in half the cases. Recurrence occurred in 4 patients (16.7%), all of whom had subtotal resections. The average follow up since diagnosis was 4.6 years (range 0.3 to 14 years). Nineteen patients presented with seizures, of which 63.2% were seizure free after surgery. The samples with molecular genetic testing (microarrays or FISH), were all normal except one patient positive for BRAF V600E mutation. CONCLUSIONS This is the first and largest review of pediatric DNETs in the last 10 years. Despite majority of patients having a favorable outcome after surgery, a subset of patients remains symptomatic. As molecular mechanisms in DNET remain unknown, future aim is to describe the molecular characteristics of our DNET population, and correlate with outcomes.
Collapse
Affiliation(s)
| | - Thomas Geller
- Johns Hopkins All Children’s Hospital, St. Petersburg, FL, USA
| | | | - Luis Rodriguez
- Johns Hopkins All Children’s Hospital, St. Petersburg, FL, USA
| | - Javier Quintana
- Johns Hopkins All Children’s Hospital, St. Petersburg, FL, USA
| | | |
Collapse
|
42
|
Fauste E, Rodrigo S, Rodriguez L, Donis C, Álvarez-Millan J, Panadero M, Otero P, Bocos C. Maternal fructose affects transsulfuration pathway of female progeny. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
43
|
Hernández-Conde M, Llop E, Carrillo CF, Tormo B, Abad J, Rodriguez L, Perelló C, Gomez ML, Martínez-Porras JL, Puga NF, Trapero-Marugan M, Fraga E, Aracil CF, Panero JLC. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26:6658-6668. [PMID: 33268953 PMCID: PMC7673970 DOI: 10.3748/wjg.v26.i42.6658] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/05/2020] [Revised: 10/09/2020] [Accepted: 10/26/2020] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Obesity is a risk factor for non-alcoholic fatty liver disease (NAFLD), although obese patients with NAFLD do not always develop significant fibrosis. The distribution of body fat could predict the risk of NAFLD progression.
AIM To investigate the role of bioelectrical impedance-estimated visceral fat (VF) in assessing NAFLD severity.
METHODS In this cross-sectional study, patients with biopsy-proven NAFLD were prospectively included. All patients underwent anthropometric evaluation, blood tests and bioelectrical impedance analysis.
RESULTS Between 2017 and 2020, 119 patients were included [66.4% male, 56 years (SD 10.7), 62.2% obese, 61.3% with metabolic syndrome]. Sixty of them (50.4%) showed significant fibrosis (≥ F2) in liver biopsy. Age, VF and metabolic syndrome were associated with significant fibrosis (61 years vs 52 years, 16.4 vs 13.1, 73.3% vs 49.2%, respectively; P < 0.001 for all). In the multivariate analysis, VF and age were independently associated with significant fibrosis (VF, OR: 1.11, 95%CI: 1.02-1.22, P = 0.02; age, OR: 1.08, 95%CI: 1.03-1.12, P < 0.01). A model including these variables showed and area under the receiver operating characteristic curve (AUROC) of 0.75, which was not inferior to transient elastography or NAFLD fibrosis score AUROCs. We developed a nomogram including age and VF for assessing significant fibrosis in routine practice.
CONCLUSION VF is a surrogate marker of liver fibrosis in patients with NAFLD. Bioelectrical impedance analysis is an inexpensive and simple method that can be combined with age to guide patient referral when other resources may be unavailable.
Collapse
Affiliation(s)
- Marta Hernández-Conde
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - Elba Llop
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
- Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas, Instituto de Salud Carlos III, Madrid 28029, Spain
| | - Carlos Fernández Carrillo
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
- Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas, Instituto de Salud Carlos III, Madrid 28029, Spain
| | - Beatriz Tormo
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - Javier Abad
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - Luis Rodriguez
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - Christie Perelló
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - Marta López Gomez
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - José Luis Martínez-Porras
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - Natalia Fernández Puga
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - Maria Trapero-Marugan
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
- Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas, Instituto de Salud Carlos III, Madrid 28029, Spain
| | - Enrique Fraga
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
- Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas, Instituto de Salud Carlos III, Madrid 28029, Spain
| | - Carlos Ferre Aracil
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
| | - José Luis Calleja Panero
- Gastroenterology and Hepatology Department, IDIPHISA, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid 28222, Spain
- Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas, Instituto de Salud Carlos III, Madrid 28029, Spain
| |
Collapse
|
44
|
Ruiz-Genao D, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Belinchón I, Gómez-García F, Herrera-Acosta E, López-Estebaranz J, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo J, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, García-Donoso C, Carrascosa J, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Descalzo M, García-Doval I. Cambios en las tendencias de la prescripción y causas de la interrupción en los tratamientos biológicos indicados en la psoriasis durante los primeros 10 años. Datos obtenidos del registro español Biobadaderm. Actas Dermo-Sifiliográficas 2020; 111:752-760. [DOI: 10.1016/j.ad.2020.05.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Accepted: 05/31/2020] [Indexed: 10/23/2022] Open
|
45
|
Ruiz-Genao D, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cuev P, Belinchón I, Gómez-García F, Herrera-Acosta E, López-Estebaranz J, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo J, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, García-Donoso C, Carrascosa J, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Descalzo M, García-Doval I. Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry. Actas Dermo-Sifiliográficas (English Edition) 2020. [DOI: 10.1016/j.adengl.2020.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
46
|
Kohut A, Kuhn T, Booher M, Naumova A, Southern G, Flowers L, Conrad L, Gordon A, Rodriguez L, Khanna N. Evaluating risk factors for surgical site infection following minimally invasive surgery for endometrial cancer. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
47
|
Cristea M, Frankel P, Synold T, Stewart D, Wang E, Jung A, Wilczynski S, Tran M, Konecny G, Eng M, Kilpatrick L, Chen YJ, Glaser S, Han E, Dellinger T, Hakim A, Lee S, Morgan R, Rodriguez L, Wakabayashi M. 863P A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in pts with selected FRα -positive solid tumours: Results in the endometrial cancer (EC) cohort. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
48
|
Selman-Geara A, Benitez-Camporro A, Defillo-Guerrero G, Ibrahim A, Redondo, Cytopathologist Y, Rodriguez L, Selman-Fermin A, Selman-Fermin AI. SAT-388 Dry Cough as Only Sign of a Parathyroid Adenoma Producer of PTH. J Endocr Soc 2020. [PMCID: PMC7208337 DOI: 10.1210/jendso/bvaa046.793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Abstract
BACKGROUND: The parathyroid adenoma producing an excess of PTH is characterized by hypercalcemia, asthenia, physical weakness and renal lithiasis. This clinical case is presented only with a dry (non-productive) cough sign of long duration.CASE: 51-year-old female born in Padre Las Casas, D.R. presenting with chief complain of dry cough for about four years. Clinical findings: (03/13/2019) Height 62”, Weight 142 lbs, Temperature 36.2 Celsius, BP 90/60 mmHg, RR 16 rpm, HR 60 bpm, on her neck no adenopathies or thyroid changes. Occasional coughing. A sonographic evaluation of the neck (04/09/2019) reveals a solid, heterogeneous nodular image of 0.7 cm x 0.5 cm in the left lobe of the Thyroid (Fig. 1) which by FNAB (04/10/2019) showed a benign adenomatoid node with cystic changes (Bethesda II) (Fig. 2). TEST: (03/20/2019) anti-TG 0.10 IU/mL (NV -115), anti-TPO 9.00 IU/mL (NV -34), TG 9.41 (NV -78 ng/mL), TSH 0.34 μIU/mL (VN 0.27-4.20), free T3 2.05 pg/mL (NV 2.04-4.40), total T3 0.74 ng/mL (NV 0.83-2.00), total T4 8.46 μg/dL (NV 5.1-14.1), free T4 1.61 ng/dL (NV 0.93-1.71) Calcium 10.4 mg/dL (NV 8.1-10.4), Phosphorus 2.6 mg/dL (NV 2.5-4.5), PTH-Intact 157 pg/mL (NV 14.5-87.1) Thyroid-Parathyroid scintigraphy (Sestamibi-Technetium 99mTc04: 15 mCi) (04/23/2019) shows lower left Parathyroid Adenoma (Fig. 3). She undergoes surgery (05/23/2019) removing the left thyroid lobe and left inferior parathyroid gland whose pathology shows chronic nodular colloid goiter, with areas of hemorrhage. Parathyroid adenoma of main cells (Fig. 4-5). Post-surgical TEST (06/24/2019) PTH-intact 69.0 pg/mL (NV 14.5-87.1), Calcium 8.6 mg/dL (NV 8.1-10.4), Phosphorus 2.7 mg/dL (NV 2.5-4.5), anti-TG 10.0 IU/mL (NV <115), anti-TPO 9.00 IU/mL (NV <34), TG 8.92 ng/mL (NV <78), total T3 0.68 ng/mL (NV 0.83-2.00), free T3 1.95 pg/mL (NV 2.04-4.40), total T4 6.40 μg/dL (NV 5.1-14.1), free T4 1.02 ng/dL (NV 0.93-1.71). Post-surgical clinical evaluation (06/21/2019) Weight 142 lbs, Temperature 36.5 Celsius, BP 110/70 mmHg, RR 16 rpm, HR 60 bpm. Patient has not shown signs of coughing. Last TESTS (10/20/2019) Calcium 9.40 mg/dL, Phosphorus 3.10 mg/dL, PTH-intact 24.40 pg/mL, TG 11.90 ng/mL, total T4 6.80 μg/dL, free T4 1.23 ng/dL, total T3 0.88 ng/mL, free T3 2.66 pg/mL, anti-TPO 11.14 IU/mL, anti-TG 10 IU/mL. CONCLUSIONS: Lower left (benign) parathyroid adenoma whose clinical manifestations are not common. Dry (non-productive) cough is not known as a manifestation of elevated PTH-intact. Calcium and Phosphorus levels in normal values. In addition, histological alterations of the left thyroid lobe of benign character with few manifestations of hormonal alterations and normal antibodies. It is of crucial clinical importance to observe and document more cases with similar presentation in order to identify the possible causes of cough with an elevated PTH manifestation.
Collapse
Affiliation(s)
| | | | | | - Ammar Ibrahim
- Universidad Central del Este, Santo Domingo, Dominican Republic
| | | | - L Rodriguez
- Clinica Dr. Abel Gonzalez, Santo Domingo, Dominican Republic
| | | | | |
Collapse
|
49
|
Coll R, Vidal J, Kumru H, Benito J, Valles M, Codinach M, Blanco M, Vives J, Querol S, Salvador F, Nogués N, Rodriguez L, Garcia J. Is HLA matching relevant for treating Spinal Cord Injury with intrathecal administration of expanded Wharton's Jelly Mesenchymal Stromal Cells? Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
50
|
Beers MF, Rodriguez L, Hawkins A, Russo SJ, Tomer Y, Mulugeta S, Katzen J. Alveolar Type 2 Epithelial Cell Quality Control Responses to Pulmonary Fibrosis Related
SFTPC
Mutations Are Dysfunctional And Substrate Specific. FASEB J 2020. [DOI: 10.1096/fasebj.2020.34.s1.05725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|